Packaged frozen ice pops of cannabis juice Purée

ABSTRACT

A method of manufacturing and packaging frozen ice pops of cannabis juice purée involves collecting raw cannabis material. Next, raw cannabis material is blended with water, fruit juice, or vegetable juice and a sweetening or flavoring agent to form cannabis juice purée. Decarboxylated or non-decarboxylated high concentrate cannabis extract or decarboxylated cannabis infusion is optionally added to the purée. Next, the purée is poured into a tube shaped plastic container. Next, the container is frozen to obtain a packaged frozen ice pop of cannabis juice purée. The cannabis ice pop is provided singularly or in a package having additional cannabis ice pops. A dispensary can store the ice pops until distribution. The package includes labeling describing amounts and types of cannabinoids in the cannabis ice pops. In one example, the cannabis ice pop is non-psychoactive and includes no decarboxylated cannabinoids. In another example, the cannabis ice pop includes decarboxylated cannabinoids.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of, and claims the benefit under 35U.S.C. § 120 from, nonprovisional U.S. patent application Ser. No.15/213,349, entitled “Packaged Frozen Ice Pops Of Cannabis Juice Puree,”filed on Jul. 18, 2016, now U.S. Pat. No. 9,955,716. U.S. patentapplication Ser. No. 15/213,349 claims the benefit under 35 U.S.C. § 119of U.S. provisional patent application Ser. No. 62/292,732, entitled“Dietary Supplement and Method of Production,” filed on Feb. 8, 2016.The subject matter of each of the foregoing documents is expresslyincorporated herein by reference.

TECHNICAL FIELD

The present disclosure relates generally to methods for manufacturingand packaging dietary supplements, and more particularly tomanufacturing and packaging cannabinoid products.

BACKGROUND INFORMATION

The cannabis plant genus is known to produce over four hundred andeighty different chemical substances, and at least eighty of thesechemical substances are classified as cannabinoids. Many cannabinoidshave been found to have diverse medicinal uses which include analgesic,anti-inflammatory, anticancer, antibioitic, anti-anxiety, andanti-oxidant properties. There are now thousands of strains of thecannabis plant that have evolved naturally or have been developedthrough hybridization. The different strains of cannabis tend to containdifferent combinations of these cannabinoids in varying amounts.

Cannabinoids found in their natural state typically are in anon-decarboxylated form. Cannabinoids can be converted into adecarboxylated form by a process referred to as decarboxylation.Decarboxylation is a chemical reaction that removes the carboxyl groupfrom a compound. In the case of cannabinoids, decarboxylation involvesremoving the carboxyl group from the cannabinoid compounds. One commontechnique for performing decarboxylation is by heating cannabis materialto 240° F. or higher for ten minutes to a few hours. Decarboxylationalso occurs in cannabis material if the material is allowed to be drycured. These cannabinoids provide different medicinal benefits when theyare in their ‘raw’ or non-decarboxylated form, compared to theirproperties after they are decarboxylated.

Two cannabinoids that show tremendous medicinal potential aretetrahydrocannabinol (THC) and cannabidiol (CBD). THC is thedecarboxylated cannabinoid that is considered to be psychoactive.However, if the cannabis material is never heated, ‘decarboxylated’, thecannabinoid will remain in its acid form, tetrahydrocannabinolic acid(THCa). THCa is not considered to be psychoactive. THCa also providesmany medicinal benefits without causing psychoactive effects for theuser. Most notably, THCa has many anti-inflammatory and cancer cellfighting properties while not being psychoactive. The cannabinoid CBDalso is present in the acid form, cannabidiolic acid (CBDa), if the rawcannabis material is not decarboxylated. But when decarboxylated, theCBDa is converted to CBD. Both CBDa and CBD have a different set ofmedicinal properties.

Because decarboxylation occurs when the cannabis material is dried orheated, it is challenging to find methods for consumers to have accessto the ‘raw’ non-decarboxylated cannabis material. Raw cannabis leavesand flowers will begin to spoil or decarboxylate after a few days ofbeing removed from the living plant. As a result, commercialdistribution of raw non-decarboxylated cannabis material has beencommercially unfeasible. A solution that overcomes these challenges isdesired.

SUMMARY

Methods of manufacturing, packaging, and storing cannabis products areprovided. In one embodiment, a plurality of frozen structures ofcannabis juice purée that comprises a pre-determined amount ofnon-decarboxylated cannabinoids is packaged and stored. In one example,the frozen structures of cannabis juice purée are frozen cubes ofcannabis juice purée. The frozen cubes are also referred to as “frozencannabis juice purée cubes” or “cubes” due to their cubic shape. Thefrozen structures of cannabis juice purée can be made to form shapesother than cubic shaped structures. The frozen cannabis juice puréecubes are administered to individuals desiring the pre-determined amountof non-decarboxylated cannabinoids. A user can combine the frozencannabis juice purée cubes with other juices, fruits, vegetables, orsupplements for consumption, for example, by adding a desired number ofthe cubes to a “smoothie” blend. The frozen cannabis juice purée cubesdo not include any decarboxylated cannabinoids. Decarboxylatedcannabinoids are formed by heating raw cannabis material therebyconverting THCa to THC. THC may have psychoactive properties. Becausethe non-decarboxylated frozen cannabis juice purée cubes do not includesuch decarboxylated cannabinoids, the frozen cannabis juice purée cubesare generally non-psychoactive. Thus, a person can consume the frozencannabis juice purée cubes and obtain therapeutic benefits while stillretaining his/her faculties to perform his/her ordinary daily routine.

The non-decarboxylated cannabinoid frozen cannabis juice purée cubes arefrozen thereby extending the shelf life of the cannabinoids within thecubes to at least six months. In conventional techniques used to collectand store non-decarboxylated cannabinoid material, thenon-decarboxylated cannabinoid material lasts only between two and threedays before spoiling. Due to the known shelf life limitations, packagingand distributing the non-decarboxylated cannabinoid material is notpractical or commercially feasible. Unfortunately, individuals whorequire the non-decarboxylated cannabinoids for treating illnesses orhealth conditions do not have ready access to a consistent supply ofnon-decarboxylated cannabinoids, especially cannabis material whichcontains the optimal levels and ratios of cannabinoids. The novelpackaged frozen cannabis juice purée cubes overcome this shortcoming byextending shelf life resulting in consistent and reliable access tocannabinoids in specific dosage amounts for individuals who require thecannabinoids to treat various medical conditions and to live morecomfortably than they would be able to otherwise.

In a first step, raw cannabis material is collected by trimming leavesor flowers of a cannabis plant. The raw cannabis material includesleaves, flowers, stems, trichomes, and other plant material from thecannabis plant. The trimmed cannabis material has a particularcannabinoid profile that has desired therapeutic qualities. Thecannabinoid profile indicates types and proportions of cannabinoidspresent in the cannabis material. Different types of cannabis plantsexhibit different cannabinoid profiles that are beneficial for certaintypes of medical conditions. The cannabinoid profile for a specificplant can be determined by a laboratory capable of performing a fullspectrum cannabinoid profiling and analysis. Such laboratories oftenemploy High Performance Liquid Chromatography (HPLC/UV) to conduct theanalysis.

In one example, the cannabis plant is selected such that the cannabinoidprofile has tetrahydrocannabinolic acid (THCa) and cannabidiolic acid(CBDa) such that the THCa to CBDa ratio is 3 CBDa to 2 THCa. This meansthat for every 3.0 milligrams of CBDa in a unit of cannabis material,there is approximately 2.0 milligrams of THCa. In another example, thecannabis profile is taken from the group consisting of: 2 CBDa to 1THCa, 1 CBDa to 1 THCa, 1 CBDa to 2 THCa, 1 CBDa to 3 THCa, 3 CBDa to 1THCa, 0 CBDa to 1 THCa (no CBDa, only THCa), and 1 CBDa to 0 THCa (noTHCa, only CBDa).

In a second step, a cannabis juice purée is formed from the collectedraw cannabis material by blending the collected raw cannabis materialalong with water and a thickening agent. The resulting cannabis juicepurée has a liquid composition and is also referred to as “a uniformpurée” or “a liquefied cannabis juice purée”. The water is filteredwater, unfiltered water, ice formed from filtered water, or ice formedfrom unfiltered water. Alternatively, fruit juice or vegetable juice canbe used in addition to or instead of water. The thickening agent aids insuspending the cannabis material thereby aiding in a uniformdistribution of cannabinoids throughout the cannabis juice purée. Auniform distribution of cannabinoids throughout the cannabis juice puréeis desired to ensure that each cube has a consistent dose ofcannabinoids. In one example, the variation in amount of cannabinoids ineach cube is 10%. Without the thickening agent, the resulting mixturewould have an upper layer with the water and a bottom layer with thecannabis material rather than a uniform mixture. The thickening agentmay be banana, avocado, psyllium husk, tapioca, or any food-gradethickening agent.

In accordance with one novel aspect, the cannabis juice purée is formedwithout a juicing process. In a juicing process, a portion of thecannabis plant material is separated from the juice of the cannabisplant. At least part of the separated cannabis plant material is treatedas waste and is disposed. To form the cannabis juice purée, however, allof the cannabis plant material is converted into the cannabis juicepurée. The resulting cannabis juice purée includes all of the cannabisplant material placed in the blender and all of the extracted cannabisjuice that is extracted in the blending process. No waste product isgenerated in forming the cannabis juice purée. Accordingly, the cannabisjuice purée has all of the cannabis plant material and is rich indietary fibers and non-cannabinoid components that include terpenes,fatty acids, aminoacids, enzymes, vitamins, minerals, carotenoids,chlorophyll, and flavonoids.

In a third step, the cannabis juice purée is deposited into molds of atray. The tray has a plurality of molds each having a substantiallyidentical size, shape, and volume. Depositing the cannabis juice puréeinto similar molds results in each cube having a substantially similaramount of cannabinoids. An individual tends to prefer reliable andconsistent doses, thus similarly sized cubes with substantially the samecannabinoid profiles are desired. In addition, by using a tray with thesame size of molds, the cubes can be effectively mass produced therebyreducing the overall cost of cubes to the consumer.

In a fourth step, the tray of molds having the cannabis juice purée isfrozen to form the frozen cannabis juice purée cubes. In one example,the tray having the cannabis juice purée is placed in a freezer having atemperature less than 5.0° F., or alternatively less than 0.0° F.Freezing the cannabis juice purée results in a shelf-life of more thansix months if the cubes are properly stored in a freezer. The cannabisjuice purée used to form the cubes does not contain any dairy product,milk-based product, or cream type of product, such as coconut milk. Thefrozen cannabis juice purée cubes are in a solid state and are frozen,solid structures that maintain their structure when placed next to eachother. The frozen cannabis juice purée cubes do not have a soft,malleable consistency such as a sorbet-type consistency or icecream-type consistency.

In a fifth step, the frozen cannabis juice purée cubes having thenon-decarboxylated cannabinoids are packaged into a package. The frozencannabis juice purée cubes are packaged in a vacuum sealed package, abag, or a container having a detachable lid. A label identifying thecontents can be placed onto the outside of the package. No additionalpackaging material is placed inside the package. The cubes are looselypacked so that they do not touch, or are tightly packed so that eachcube contacts at least one other cube. Because the frozen cannabis juicepurée cubes are frozen prior to packaging and the purée recipe freezesto a hardness similar to ice (not a soft malleable texture like icecream or sorbet), the frozen cannabis juice purée cubes can contact eachother inside the package without damaging their integrity or dosageamount per cube. Each cube has at least one surface that directlycontacts a surface of the package. Each cube is adjacent to at least twoother cubes. The cubes within the package consume over 95% of the totalvolume of package. In addition, the package of cubes has at least twoflat surfaces thereby providing optimal storing and transportingcharacteristics. In another example, the cubes are stacked so that notall of the cubes contact the package.

In accordance with another novel aspect, a plurality of packages havingfrozen cannabis juice purée cubes with only non-decarboxylatedcannabinoids is stored. The packages are stored in a freezer by stackingeach package above another package. Each package has at least two flatsurfaces due to the uniform size and shape of each cube. Accordingly,the packages stack compactly in the freezer. In one example, amanufacturing entity manufactures and provides the packaged frozencannabis juice purée cubes with only non-decarboxylated cannabinoids toa dispensary entity. The dispensary entity handles storing the packagedcubes until the packaged cubes are provided to end consumers.

In a second embodiment, the packaged frozen cannabis juice purée cubescomprise non-decarboxylated cannabinoids and decarboxylatedcannabinoids. The amount of decarboxylated cannabinoids in each frozenstructure is at least 5 mg. A structure with less than 5 mg is notconsidered to be a therapeutic dose of decarboxylated cannabinoidsbecause consuming less than 5 mg decarboxylated cannabinoids hasnegligible, if any, effects on the user. The amount of decarboxylatedcannabinoids may include one type of decarboxylated cannabinoid (such asCBD) or more than one type of decarboxylated cannabinoid (such as CBDand THC).

The packaged frozen cannabis juice purée cubes with bothnon-decarboxylated cannabinoids and decarboxylated cannabinoids providesconsumers with a full spectrum of THCa, THC, CBDa, CBD, and all of theother cannabis compounds in both the non-decarboxylated anddecarboxylated forms, in one easy-to-consume frozen purée cube. Thefrozen cannabis juice purée cubes include at least one cannabinoid takenfrom the group consisting of: cannabigerolic acid (CBGa),cannabigerovarin acid (CBGVA), tetrahydrocannabinolic acid (THCA),tetrahydrocannabivarin carboxylic acid (THCVA), cannadidiolic acid(CBDA), cannabidivarin acid (CBDVA), cannabichrome carboxylic acid(CBCA), cannabichrome varinic acid (CBCVA), tetrahydrocannabinol (THC),tetrahydrocannabidivarin (THCV), tetrahydrocannabivarin acid (THVA),cannabidiol (CBD), cannabidivarin (CBDV), cannabichromene (CBC),cannabichromevarin (CBCV), cannabigerol (CBG), cannabigerovarin (CBGV),cannabinerolic acid (CBNA), cannabigerovarinic acid (CBNVA), cannabinol(CBN), cannabicyclol (CBL), and cannabicyclol acid (CBLA).

In a first step, two separate portions of raw cannabis material arecollected. The first portion of raw cannabis material may come from astrain of cannabis with a unique cannabinoid ratio (for example, 3 CBDato 2 THCa). This first portion will remain in its non-decarboxylatedstate. Other cannabinoid ratios in the first portion include: 2 CBDa to1 THCa, 1 CBDa to 1 THCa, 1 CBDa to 2 THCa, 1 CBDa to 3 THCa, 3 CBDa to1 THCa, 0 CBDa to 1 THCa (no CBDa, only THCa), and 1 CBDa to 0 THCa (noTHCa, only CBDa). The second portion of cannabis is collected from adifferent strain of cannabis plant with a different unique cannabinoidprofile (for example, 30 CBDa to 1 THCa). This second portion will laterbe decarboxylated. When this second portion is decarboxylated, the ratioof the decarboxylated cannabinoids becomes 30 CBD to 1 THC. Othercannabinoid ratios in the decarboxylated second portion include: 20 CBDto 1 THC, 10 CBD to 1 THC, or 5 CBD to 1 THC.

In an alternative step, the first portion (non-decarboxylated portion)of raw cannabis material and the second portion (to be decarboxylated)of raw cannabis material are collected from the same strain of cannabisplant with the exact same cannabinoid profile. In one example, the firstportion Is 3 CBDa to 2 THCa, and the second portion is also 3 CBDa to 2THCa. Once decarboxylated, the second portion will convert to a ratio of3 CBD to 2 THC. Other combinations of cannabinoid materials havingdifferent cannabinoid profiles can be selected depending upon thedesired therapeutic effects or medical conditions being targeted. Anartisan of ordinary skill would appreciate the vast number ofcombinations of types and amounts of cannabinoids that can be used tocreate the cubes.

In a second step, a non-decarboxylated cannabis juice purée is formedfrom the first portion of raw cannabis material and a decarboxylatedcannabis infusion is formed from the second portion of raw cannabismaterial. The non-decarboxylated cannabis juice purée is formed byblending the first portion of collected raw cannabis material along withwater and a thickening agent. The decarboxylated cannabis infusion isformed by heating the second portion of collected raw cannabis material.Decarboxylating cannabis material can be achieved through heating thecannabis material at a temperature of 240° F. for 30 minutes or longerin a mixture of fatty oil. Decarboxylating cannabis material can also beachieved through heating the cannabis material in an oven without anyoil or substance.

In a third step, the non-decarboxylated cannabis juice purée and thedecarboxylated cannabis infusion are deposited into molds of a tray suchthat each mold has non-decarboxylated and decarboxylated cannabinoids.The non-decarboxylated cannabis juice purée is deposited into each moldto fill approximately half of the mold. Next, the decarboxylatedcannabis infusion is deposited at a center location on the top surfaceof the half-filled mold. Next, the non-decarboxylated cannabis juicepurée is deposited above the decarboxylated cannabis infusion to fillthe rest of each mold.

Alternatively, the decarboxylated cannabis infusion is deposited intothe non-decarboxylated cannabis juice purée during the blending process.By adding the decarboxylated cannabis infusion during the blendingprocess, the decarboxylated cannabinoids are uniformly distributedthroughout the cannabis juice purée resulting in a uniform distributionof cannabinoids in each cube after the freezing process.

In a fourth step, the tray of molds having the cannabis juice purée isfrozen to form the frozen cannabis juice purée cubes havingnon-decarboxylated and decarboxylated cannabinoids. The cannabis juicepurée used to form the cubes does not contain any dairy product,milk-based product, or cream type of product, such as coconut milk. Thetray of molds having the cannabis juice purée is placed in a freezerhaving a temperature less than 5.0° F., or alternatively less than 0.0°F. Freezing the cannabis juice purée results in an extended shelf-lifeof at least six months if the frozen cannabis juice purée cubes areproperly stored in a freezer. The frozen cannabis juice purée cubes arein a solid state and are frozen, solid structures that maintain theirstructure when placed next to each other. The frozen cannabis juicepurée cubes do not have a soft, malleable consistency such as asorbet-type consistency or ice cream-type consistency.

In a fifth step, the frozen cannabis juice purée cubes having thenon-decarboxylated and decarboxylated cannabinoids are packaged into apackage. The frozen cannabis juice purée cubes are packaged in a vacuumsealed package, a bag, or a container having a detachable lid. A labelidentifying the contents can be placed onto the outside of the package.No additional packaging material is placed inside the package. The cubesare loosely packed so that not all of the cubes contact each other, orare tightly packed so that each cube contacts at least one other cube.Because the frozen cannabis juice purée cubes are frozen prior topackaging and the purée recipe freezes to a hardness similar to ice (nota soft malleable texture like ice cream or sorbet), the frozen cannabisjuice purée cubes can contact each other inside the package withoutdamaging their integrity or dosage amount per cube. Each cube has atleast one surface that directly contacts a surface of the package. Eachcube is adjacent to at least two other cubes. The cubes within thepackage consume over 95% of the total volume of package. In addition,the package of cubes has at least two flat surfaces thereby providingoptimal storing and transporting characteristics. In another example,the cubes are stacked so that not all of the cubes contact the package.

In accordance with another novel aspect, a plurality of packages havingfrozen cannabis juice purée cubes is stored. The packages are stored ina freezer by stacking each package above another package. Each packagehas at least two flat surfaces due to the uniform size and shape of eachcube. Accordingly, the packages stack compactly in the freezer. In oneexample, a manufacturing entity manufactures and provides the packagedfrozen cannabis juice purée cubes to a dispensary entity. The dispensaryentity handles storing the packaged cubes until the packaged cubes areprovided to end consumers.

In a third embodiment, a method of manufacturing and packaging frozenice pops of cannabis juice purée is provided. The resulting packagedfrozen ice pops of cannabis juice purée are also referred to as a“frozen cannabis to go pack”, “frozen cannabis on the go pop”, “frozencannabis icicle”, or “frozen cannabis popsicle”. In one specificembodiment, the packaged frozen ice pop of cannabis juice purée has anamount of non-decarboxylated cannabinoids and is non-psychoactive. Inanother specific embodiment, the packaged frozen ice pop of cannabisjuice purée has an amount of non-decarboxylated cannabinoids and anamount of decarboxylated cannabinoids.

In a first step, a cannabis juice purée is formed. To form a packagedfrozen ice pop of cannabis juice purée that is non-psychoactive, rawcannabis material having an amount of non-decarboxylated cannabinoids iscollected but never heated. The amount of non-decarboxylatedcannabinoids is blended together with a thickening agent and asweetening agent such as honey, stevia, fruit juice, sugar, or cornsyrup. The sweetening agent is optional and is not included in someembodiments. Flavoring agents are included in other embodiments, such asfruit flavor or spice (apple, cherry, mint, tart, etc.). Fruit juice,fruit, or vegetable material may also be added, such as blueberries,blueberry juice, carrots, or carrot juice. Non-decarboxylated highconcentrate cannabis extract may also be added to the cannabis juicepurée prior to freezing to increase the amount of non-decarboxylatedcannabinoids in each ice pop.

To form a packaged frozen ice pop of cannabis juice purée that hasdecarboxylated cannabinoids, a portion of the collected raw cannabismaterial is heated to obtain an amount of decarboxylated cannabinoids.The amount of decarboxylated cannabinoids are added to the cannabisjuice purée prior to freezing. Non-decarboxylated high concentratecannabis extract, decarboxylated high concentrate cannabis extract,decarboxylated cannabis infusion, or heated cannabis material may alsobe added to the cannabis juice purée prior to freezing to increase theamount of non-decarboxylated and decarboxylated cannabinoids in each icepop.

In a second step, the cannabis juice purée is deposited into acontainer. In one example, the container is a tube shaped container madeof a flexible material. The container is a tube shaped container formedfrom a thermoplastic polymer such as polypropylene plastic resin. In oneexample, the tube shaped container has a resealable end. In anotherexample, the tube shaped container is not resealable and a user mustpermanently tear a portion of the container to access the frozen ice popof cannabis juice purée.

In a third step, the container having the cannabis juice purée is frozento form a packaged frozen ice pop of cannabis juice purée. The containerhaving the cannabis juice purée is placed in a freezer so that thecannabis juice purée in the container (along with any added cannabisinfusion or high concentrate cannabis extract) can freeze. Thetemperature within the freezer is typically between 0.0° F. and 5.0° F.,but may be less than 0.0° F. The resulting frozen ice pop of cannabisjuice purée assumes the shape of the container. In one example, packagedfrozen ice pop of cannabis juice purée is a cylindrical tube shapedstructure.

In a fourth embodiment, a method of manufacturing and packaging acannabis juice purée is provided. In one specific embodiment, thepackaged cannabis juice purée has an amount of non-decarboxylatedcannabinoids and is non-psychoactive. In another specific embodiment,the packaged cannabis juice purée has an amount of non-decarboxylatedcannabinoids and an amount of decarboxylated cannabinoids.

In a first step, a cannabis juice purée is formed. To form a packagedcannabis juice purée that is non-psychoactive, raw cannabis materialhaving an amount of non-decarboxylated cannabinoids is collected butnever heated. The raw cannabis material is blended together with athickening agent and a sweetening agent such as honey, stevia, fruitjuice, sugar, or corn syrup. Non-decarboxylated high concentratecannabis extract may also be added to the cannabis juice purée toincrease the amount of non-decarboxylated cannabinoids in eachcontainer.

To form a packaged cannabis juice purée that comprises decarboxylatedcannabinoids, a portion of the collected raw cannabis material is heatedto obtain an amount of decarboxylated cannabinoids. The amount ofdecarboxylated cannabinoids are added to the cannabis juice purée.Non-decarboxylated high concentrate cannabis extract, decarboxylatedhigh concentrate cannabis extract, decarboxylated cannabis infusion, orheated cannabis material may also be added to the cannabis juice puréeto increase the amount of non-decarboxylated and decarboxylatedcannabinoids in each container.

In a second step, cannabis juice purée is deposited into a container.The container is a cylindrical shaped structure having a lid. Thecontainer is formed from a glass material, a plastic material, or apaper-based material. The cannabis juice purée is deposited into thecontainer through an opening.

In a third step, the container having the cannabis juice purée ispackaged. In one example, the cannabis juice purée is processed usinghigh pressure processing (HPP). In HPP, the cannabis juice purée isloaded into a high pressure chamber filled with pressure transmittingfluid, such as water. The pressure is applied to the cannabis juicepurée. A lid is used to seal the opening of the container.

HPP allows the mixture to be pastuerized without applying heat. HPPextends shelf life of the cannabis juice purée to several weeks tomonths without applying heat that could undesirably decarboxylate thecannabinoids present in the cannabis juice purée. Thus, shelf life ispreserved while providing a liquid beverage form of cannabis juicepurée.

Forming the cannabis juice purée and freezing cannabis juice purée intoserving size cubes or ice pops is a significant improvement over theconventional art. Significant research and testing was involved toascertain the optimal process and technique. For example, thisdevelopment process involves selecting the most effective strains ofcannabis having optimal cannabinoid profiles, determining the effectiveproportions and amounts of materials to combine to ensure a consistentdosage amount of cannabinoids per serving, and selecting the optimaltechnique for creating the cannabis juice purée, selecting the size andshape of the cube, and determining the most efficient and convenientpackaging for the end consumer.

In particular, the invention yields significant advantages over priorattempts of forming mixture via juicing machines or wheat grass juicers.For example, prior attempts using conventional juicing machines or wheatgrass juicers resulted in very little juice and substantial leaf pulp.The conventional juicing machines or wheat grass juicers were notpowerful enough to blend the raw cannabis leaves into the smooth puréeconsistency that is desired for the cannabis juice purée. Suchconventional blenders generated leaf pulp that was too thick andabrasive for consumption. However, a high powered juice blender (such asa Vitamix blender) with water and banana achieved the most desirablecannabis juice purée having the proper texture and purée composition. Inaddition, without the banana, the cannabis juice purée separated intoraw cannabis material on bottom and water on top.

In addition, conventional techniques did not have the proper size andshape to achieve a dosage of over 20 milligrams of cannabinoids percube. The recipe, cube size, and technique for creating the cubesresulted from substantial laboratory testing to achieve the desiredresults. Consequently, one of ordinary skill will appreciate that thevarious novel embodiments allow the mass market to have reliable andcost effective access to non-decarboxylated cannabis material whichcontains consistent levels of THCa, CBDa, and all of the othernon-decarboxylated cannabinoids present in raw cannabis material.

One technique for making “marijuana juice” ice cubes is known. To make“marijuana juice” ice cubes, a juice extractor is used to extract“marijuana juice” from leaves of cannabis plants. The extracted“marijuana juice” is used to make ice cubes. Several shortcomings existwith this technique. First, using a juice extractor removes manynon-cannabinoid components present in the cannabis plant material(stems, leaves, flowers, etc.) that offer significant nutritional value.Second, juice extractors tend to emit heat during use, especiallyextended use, and this emitted heat may undesirably decarboxylate thecannabinoids present in the leaves. Such overheating also renders juiceextractors inefficient for commercial production. Third, the “marijuanajuice” ice cubes do not have consistent doses of cannabinoids in eachice cube. One ice cube may have more cannabinoids than another ice cube.Consistent dosage is essential for patients who require specific amountsof cannabinoids to treat illness and who also require consistent dosesto monitor progress and adjust cannabinoid intake as needed.Additionally, many patients require specific ratios of one cannabinoidto another cannabinoid for achieving desired medical benefits. The“marijuana juice” ice cubes do not yield consistent doses ofcannabinoids or specific ratios of cannabinoids. Fourth, the “marijuanajuice” ice cubes are not packaged and are meant to be removed from anice cube tray to be consumed by the user. Typical patients requireconsistent access to cannabinoids. Packaging the “marijuana juice” icecubes is difficult because the ice cubes can meld together causingadditional inconsistencies in dosage amounts. No effective way topackage, store, and commercially distribute the “marijuana juice” icecubes is known. Consequently, the “marijuana juice” ice cubes are not acommercially viable technique for administering cannabinoids along withcannabis plant material rich in nutrients that are stored and packagedfor mass distribution. Lastly, no technique is known for adding highconcentrate cannabis extract or cannabis infusion to the “marijuanajuice” ice cubes. Many patients require high amounts of specificnon-decarboxylated or decarboxylated cannabinoids which is not feasibleto achieve by consuming the “marijuana juice” ice cubes. The novelpackaged frozen cannabis juice purée cubes solve all of theseshortcomings.

The foregoing is a summary and thus contains, by necessity,simplifications, generalizations and omissions of detail; consequentlyit is appreciated that the summary is illustrative only. Still othermethods, and structures and details are set forth in the detaileddescription below. This summary does not purport to define theinvention. The invention is defined by the claims.

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, where like numerals indicate like components,illustrate embodiments of the invention.

FIG. 1 is a flowchart of a method 100 in accordance with one embodiment.

FIG. 2 is a perspective diagram showing how raw cannabis material 112 iscollected by trimming leaves 113 from the cannabis plant 111.

FIG. 3 is a perspective diagram showing how the cannabis juice purée isformed.

FIG. 4 is a perspective diagram showing how the cannabis juice purée 131is deposited into molds 132.

FIG. 5 is a perspective diagram showing how the tray 133 is placed in afreezer 141.

FIG. 6 is a perspective diagram showing how the frozen cannabis juicepurée cubes 151 are removed from tray 133 and placed on vacuum sealedbag 152.

FIG. 7 is a perspective diagram of a package 154 with the frozencannabis juice purée cubes 151.

FIG. 8 is a side view of the package 154 with the cubes 151.

FIG. 9 is top view of the package 154 with the frozen cannabis juicepurée cubes 151.

FIG. 10A is a perspective diagram of frozen cannabis juice purée cubes151 having an amount of non-decarboxylated cannabinoids.

FIG. 10B is a perspective diagram of another embodiment of the frozenstructures where an amount of non-decarboxylated high concentratecannabis extract has been added to the cannabis juice purée prior tofreezing.

FIG. 10C is a diagram of a female cannabis plant with flowers 165 havingtrichomes 164.

FIG. 10D is a table 170 showing various non-cannabinoid components andcannabinoid components that are obtainable from cannabis plant material.

FIG. 11 is a table 163 showing two general types of non-decarboxylatedcannabinoids.

FIG. 12 is a flowchart of a method 200 in accordance with a secondembodiment.

FIG. 13 is a perspective diagram showing how raw cannabis material 211is collected from a first cannabis plant 212 and a second cannabis plant213.

FIG. 14 is a perspective diagram showing how the non-decarboxylatedcannabis juice purée is formed.

FIG. 15 is a perspective diagram showing how to make a decarboxylatedcannabis infusion.

FIG. 16 is a perspective diagram showing how the non-decarboxylatedcannabis juice purée 231 and the decarboxylated cannabis infusion 234are deposited into molds 232.

FIG. 17 is a perspective diagram showing how the tray 233 is placed in afreezer 242.

FIG. 18 is a perspective diagram showing how the frozen cannabis juicepurée cubes 251 are removed from the tray 233 and placed on vacuumsealed bag 252.

FIG. 19 is a perspective diagram of a package 254 with the frozencannabis juice purée cubes 251.

FIG. 20 is a side view of the package 254 with the frozen cannabis juicepurée cubes 251.

FIG. 21 is top view of the package 254 with the frozen cannabis juicepurée cubes 251.

FIG. 22A is a perspective diagram of frozen cannabis juice purée cubes251 having an amount of non-decarboxylated cannabinoids and an amount ofdecarboxylated cannabinoids.

FIG. 22B is a perspective diagram of another embodiment of frozenstructures of cannabis juice purée with added decarboxylated cannabisinfusion and non-decarboxylated high concentrate cannabis extract.

FIG. 22C is a perspective diagram of another embodiment of frozenstructures of cannabis juice purée with added decarboxylated highconcentrate cannabis extract.

FIG. 22D is a perspective diagram of another embodiment of frozenstructures of cannabis juice purée with added decarboxylated highconcentrate cannabis extract and non-decarboxylated high concentratecannabis extract.

FIG. 23 is a table 263 showing two general types of decarboxylatedcannabinoids, THC and CBD, along with their chemical names andstructural formulas.

FIG. 24 is a flowchart of a method 300 in accordance with another novelaspect.

FIG. 25 is a perspective diagram showing how a plurality of packages 311is stored in a freezer 312.

FIG. 26 is a perspective diagram of a tray 400 having a plurality ofmolds 401.

FIG. 27 is a top view of the tray 400 having a plurality of molds 401.

FIG. 28 is a top view of a tray 403 having a plurality of cylindricalshaped molds.

FIG. 29 is a top view of a tray 404 having a plurality of rectangularshaped molds.

FIG. 30 is a top view of a tray 405 having a plurality of hexagonalshaped molds.

FIG. 31 is a top view of a tray 406 having a plurality of triangularshaped molds.

FIG. 32 is a top view of a tray 407 having a plurality of star shapedmolds.

FIG. 33 is a top view of a tray 408 having a plurality of trapezoidalshaped molds.

FIG. 34 is a top view of a tray 409 having a plurality of concave shapedmolds.

FIG. 35 is a top view of a tray 410 having a plurality of parallelogramshaped molds.

FIG. 36 is a top view of a tray 411 having a plurality of leaf shapedmolds.

FIG. 37 is a diagram of a conventional coconut milk based cannabis icecream 420.

FIG. 38 is a diagram showing how the container 421 is placed onto acontainer holder 423.

FIG. 39 is a diagram showing how the container holder 423 having sixcontainers is placed into a package 425.

FIG. 40 is a diagram of the package 425 containing the container holder423 having the six containers with coconut milk based cannabis icecreams.

FIG. 41 is a table 500 showing the advantages of novel package 154(shown in FIG. 7) and novel package 254 (shown in FIG. 19) over theconventional package 425 shown in FIG. 40.

FIG. 42 is a flowchart of a method 600 in accordance with a thirdembodiment.

FIG. 43 is a perspective diagram showing how the cannabis juice purée621 is deposited into container 622.

FIG. 44 is a perspective diagram showing how the container 622 havingthe cannabis juice purée 621 is placed in a freezer 631.

FIG. 45A is a perspective diagram of the packaged frozen ice pop ofcannabis juice purée 632 with only non-decarboxylated cannabinoids.

FIG. 45B is a perspective diagram of another embodiment of a packagedfrozen ice pop of cannabis juice purée with added non-decarboxylatedhigh concentrate cannabis extract.

FIG. 46A is a perspective diagram of a packaged frozen ice pop ofcannabis juice purée 634 with added decarboxylated cannabinoids.

FIG. 46B is a perspective diagram of another embodiment of a packagedfrozen ice pop of cannabis juice purée with added decarboxylatedcannabis infusion and non-decarboxylated high concentrate cannabisextract.

FIG. 46C is a perspective diagram of another embodiment of a packagedfrozen ice pop of cannabis juice purée with added decarboxylated highconcentrate cannabis extract.

FIG. 46D is a perspective diagram of another embodiment of a packagedfrozen ice pop of cannabis juice purée with added decarboxylated highconcentrate cannabis extract and non-decarboxylated high concentratecannabis extract.

FIG. 47 is a diagram of a user 635 consuming the packaged frozen ice popof cannabis juice purée 632/634.

FIG. 48 is a diagram of a side view of the packaged frozen ice pop ofcannabis juice purée 632/634.

FIG. 49 is a diagram of a top view of the packaged frozen ice pop ofcannabis juice purée 632/634.

FIG. 50 is a diagram of a side view of another embodiment of a packagedfrozen ice pop of cannabis juice purée 650 having a container 651 thatis not resealable.

FIG. 51 is a flowchart of a method 700 to package a plurality ofpackaged frozen ice pops of cannabis juice purées.

FIG. 52 is a perspective diagram showing how a plurality of packagedfrozen ice pops of cannabis juice purées 711 is placed inside a package712.

FIG. 53 is a flowchart of a method 800 to store packages comprising aplurality of packaged frozen ice pops of cannabis juice purée.

FIG. 54 is a perspective diagram showing how a plurality of packages 811are stored in a freezer 812.

FIG. 55 is a flowchart of a method 900 in accordance with fourthembodiment.

FIG. 56 is a perspective diagram showing how the cannabis juice purée921 is deposited into a container 922.

FIG. 57 is a perspective diagram of performing high pressure processing(HPP) during the packaging of the cannabis juice purée 921.

FIG. 58A is a perspective diagram of the packaged cannabis juice puréewith only non-decarboxylated cannabinoids.

FIG. 58B is a perspective diagram of another embodiment of a packagedcannabis juice purée with added non-decarboxylated high concentratecannabis extract.

FIG. 59A is a perspective diagram of a packaged cannabis juice puréehaving decarboxylated cannabinoids.

FIG. 59B is a perspective diagram of another embodiment of a packagedcannabis juice purée with added decarboxylated cannabis infusion andnon-decarboxylated high concentrate cannabis extract.

FIG. 59C is a perspective diagram of another embodiment of a packagedcannabis juice purée with added decarboxylated high concentrate cannabisextract.

FIG. 59D is a perspective diagram of another embodiment of a packagedcannabis juice purée with added decarboxylated high concentrate cannabisextract and non-decarboxylated high concentrate cannabis extract.

FIG. 60 is a flowchart of a method 1000 to store packaged containershaving a cannabis juice purée.

FIG. 61 is a perspective diagram of containers 1011 each having acannabis juice purée that are stored on a shelf 1012.

FIG. 62 is a table 1100 that shows the therapeutic benefits of varioustypes of cannabinoids.

Reference will now be made in detail to some embodiments of theinvention, examples of which are illustrated in the accompanyingdrawings.

DETAILED DESCRIPTION

FIG. 1 is a flowchart of a method 100 in accordance with one embodiment.The method 100 is a method of manufacturing and packaging a plurality offrozen structures of cannabis juice purée that comprises apre-determined amount of non-decarboxylated cannabinoids.

In a first step (step 110), raw cannabis material is collected. The rawcannabis material includes an amount of non-decarboxylated cannabinoids.The term “non-decarboxylated” means that the cannabinoids are in theiracid form. Non-decarboxylated cannabinoids are not considered to bepsychoactive. For example, in FIG. 2, raw cannabis material 112 iscollected by trimming leaves 113 from the cannabis plant 111. Thecannabinoid profile indicates types and proportions of cannabinoidspresent in the cannabis material. An example of a cannabinoid profile isshown in FIG. 10A where the cannabinoid contents of the cubes is shown.

The cannabis plant 111 is cultivated to have a specific cannabinoidprofile. Different cannabinoid profiles yield different therapeuticbenefits appreciated by an artisan of ordinary skill. In this example,the cannabis plant 111 has a cannabinoid profile that includestetrahydrocannabinolic acid (THCa) and cannabidiolic acid (CBDa). Thecannabis plant 111 is selected having a cannabinoid profile where theamount of THCa and CBDa is present in a desired ratio. In the example ofFIG. 2, the ratio is 3 CBDa to 2 THCa. In other examples, the ratio istaken from the group consisting of: 2 CBDa to 1 THCa, 1 CBDa to 1 THCa,1 CBDa to 2 THCa, 1 CBDa to 3 THCa, 3 CBDa to 1 THCa, 0 CBDa to 1 THCa(no CBDa, only THCa), and 1 CBDa to 0 THCa (no THCa, only CBDa).

For additional information on cannabinoid profiles, their therapeuticbenefits, and techniques for delivering the cannabinoids to a user, see:(1) U.S. Pat. No. 9,220,294, entitled “Methods and Devices UsingCannabis Vapors”, filed Apr. 29, 2014 by McCullough; (2) U.S. Pat. No.9,205,063, entitled “Cannabinoid-containing Plant Extracts AsNeuroprotective Agents”, filed Jan. 24, 2014 by Guy et al.; (3) U.S.Pat. No. 9,186,386, entitled “Pharmaceutical Composition And Method OfManufacturing”, filed May 28, 2015 by Speier; (4) U.S. Pat. No.9,155,767, entitled “Essential Element Management”, filed Oct. 18, 2012by Hospodor et al.; (5) U.S. Pat. No. 9,149,499, entitled “CannabisBased Therapeutic And Method Of Use”, filed May 19, 2014 by Robinson;(6) U.S. Pat. No. 9,095,563, entitled “Topical Treatments IncorporatingCannabis Sp. Derived Botanical Drug Product”, filed Sep. 26, 2014 bySekura et al.; (7) U.S. Pat. No. 9,095,544, entitled “Breeding,Production, Processing and Use of Specialty Cannabis”, filed Mar. 17,2014 by Lewis et al.; (8) U.S. Pat. No. 9,078,838, entitled “Cosmetic orDermatological Compositions Comprising A Mixture Of Essential Oils, AndIts Uses Thereof, Particularly For The Care Of Sensitive Or SensitizedSkin”, filed Sep. 3, 2009 by Andre et al.; (9) U.S. Pat. No. 9,066,910,entitled “Methods and Compositions of Cannabis Extracts”, filed Apr. 15,2010 by Rosenblatt et al.; (10) U.S. Pat. No. 9,050,631, entitled“Apparatus and Related Methods For Extracting Resins From Cannabis”,filed Feb. 6, 2013 by Raichart; and (11) U.S. Pat. No. 9,044,390,entitled “Pharmaceutical Composition And Method Of Manufacturing”, filedApr. 17, 2014 by Speier (the subject matter of these patent documents isincorporated herein in its entirety).

In a second step (step 120), a cannabis juice purée is formed from thecollected raw cannabis material. The cannabis juice purée has a liquidcomposition and is also referred to as a uniform purée. For example, inFIG. 3, the raw cannabis material 112 is blended in a blender 121 withwater 122 and a thickening agent 123 to form a cannabis juice purée. Inone example, 210.0 grams of fresh cannabis leaves, 200.0 grams ofbanana, and 20.0 ounces of filtered water are combined in blender 121and blended together. The blender 121 is not a juicing machine. Both theshredded cannabis plant material and the extracted cannabis juice remainin the blender after the blending process and become part of theresulting cannabis juice purée.

In accordance with one novel aspect, the cannabis juice purée is formedwithout a juicing process. In a juicing process, a portion of thecannabis plant material is separated from the juice of the cannabisplant. At least part of the separated cannabis plant material is treatedas waste and is disposed. To form the cannabis juice purée, however, allof the cannabis plant material is converted into the cannabis juicepurée. The resulting cannabis juice purée includes all of the cannabisplant material placed in the blender and all of the extracted cannabisjuice that is extracted in the blending process. No waste product isgenerated in forming the cannabis juice purée. Accordingly, the cannabisjuice purée has all of the cannabis plant material and is rich indietary fibers and non-cannabinoid components that include terpenes,fatty acids, aminoacids, enzymes, vitamins, minerals, carotenoids,chlorophyll, and flavonoids.

The water 122 may be filtered water, unfiltered water, ice formed fromfiltered water, or ice formed from unfiltered water. Alternatively,fruit juice or vegetable juice can be used in addition to or instead ofwater. The thickening agent 123 aids in suspending the cannabis materialthroughout thereby yielding a more uniform distribution of cannabinoidsthan would otherwise be achieved without the thickening agent 123. If nothickening agent 123 is used, then blending the cannabis material 112and water 122 results in a mixture having the cannabis material sinkingto the bottom with water disposed above the cannabis material. Thethickening agent 123 may be banana, avocado, psyllium husk, tapioca, orany other food-grade thickening agent.

In a third step (step 130), the cannabis juice purée is deposited intomolds of a tray. The tray has a plurality of molds each having asubstantially identical size, shape, and volume. Depositing the cannabisjuice purée into similar molds results in each cube having asubstantially similar cannabinoid profile. For example, in FIG. 4, thecannabis juice purée 131 is deposited into molds 132 of a tray 133. Inthe embodiment of FIG. 4, the tray 133 has fifteen cubic shaped moldsthat each holds one fluid ounce. The size, shape, and volume of eachmold and the number of molds on the tray are selected depending on thedesired size of the frozen cannabis juice purée cubes and amount ofcannabinoids to be delivered in each dose.

In a fourth step (step 140), the tray of molds having the cannabis juicepurée are frozen to form frozen structures of cannabis juice purée. Inone example, frozen structures of cannabis juice purée are frozencannabis juice purée cubes. In FIG. 5, for example, the tray 133 ofmolds 132 having the cannabis juice purée 131 is placed in a freezer 141so that the cannabis juice purée 131 in each mold of tray 133 canfreeze. The temperature within freezer 141 is typically between 0.0° F.and 5.0° F., but may be less than 0.0° F. Freezing the cannabis juicepurée promotes preservation because harvested raw cannabis material isnot acceptable for consumption after three days, even when the cannabismaterial is stored in a refrigerator. However, by freezing the cannabisjuice purée to form frozen cannabis juice purée cubes, the shelf-life isextended for at least six months if the frozen cannabis juice puréecubes are properly stored in a freezer.

In a fifth step (step 150), the frozen structures of cannabis juicepurée are packaged into a package. The frozen structures of cannabisjuice purée are packaged in a vacuum sealed package, a bag, or acontainer having a detachable lid. The frozen structures may be looselypacked or may directly contact each other. In the example of FIG. 6, thefrozen cannabis juice purée cubes 151 are removed from the molds 132 ofthe tray 133 and are placed on vacuum sealed bag 152. The vacuum sealedbag 152 is sealed by vacuum sealing machine 153 to form a vacuum sealedpackage having the frozen cannabis juice purée cubes 151.

FIG. 7 is a perspective diagram of a package 154 with the frozencannabis juice purée cubes 151. The frozen cannabis juice purée cubes151 have non-decarboxylated cannabinoids because the cannabis material112 involved in forming the cubes 151 has not been heated. The package154 delivers the frozen cannabis juice purée cubes 151 cheaply becausethe only packaging material involved is the vacuum sealed bag. Thepackage 154 provides for optimal storing, packing, and transportingbecause the packages are rectangular or square and have flat surfacesthat allow the packages to be stacked above each other. The frozencannabis juice purée cubes 151 consume over 95% of the total volume ofpackage 154 allowing for maximum delivery of frozen cannabis juice puréecubes per shipment of packages.

FIG. 8 is a side view of the package 154 with the cubes 151. The package154 has an upper portion 155 and a lower portion 156. Each of the cubes151 has an upper surface 157 and a lower surface 158. Each upper surface157 of the cubes contacts the upper portion 155 of the package 154 andeach lower surface 158 of the cubes 151 contacts a lower portion 156 ofthe package 154. No packaging material is disposed within the package.

FIG. 9 is top view of the package 154 with the frozen cannabis juicepurée cubes 151. The frozen cannabis juice purée cubes 151 are packagedin an array formation. Each of the frozen cannabis juice purée cubes 151has a substantially identical shape and each cube is adjacent to atleast one other cube. Reference numeral 159 identifies a surface of onecube adjacent to a surface of another cube. Each cube has at least twosurfaces that are adjacent to surfaces of at least two other cubes.

Reference numeral 160 identifies a cube along a corner of the array ofcubes 151 having a first surface that is adjacent to a surface of asecond cube and a second surface that is adjacent to a surface of athird cube. Cube 160 has two surfaces each of which contacts a surfaceof one of two other cubes. Reference numeral 161 identifies a cube alongan edge of the array of cubes 151 having a first surface that isadjacent to a surface of a second cube, a second surface that isadjacent to a surface of a third cube, and a third surface that isadjacent to a surface of a fourth cube. Cube 161 has three surfaces eachof which contacts a surface of one of three other cubes. Referencenumeral 162 identifies a cube at an inner portion of the array of cubes151 having a first surface that is adjacent to a surface of a secondcube, a second surface that is adjacent to a surface of a third cube, athird surface that is adjacent to a surface of a fourth cube, and afourth surface that is adjacent to a surface of a fifth cube. Cube 162has four surfaces each of which contacts a surface of one of four othercubes.

In accordance with at least one novel aspect, the cubes 151 are notcontained in separate containers. No packaging material is presentbetween the cubes 151. Although a gap is shown between the cubes 151,some or all of the cubes 151 may be directly contacting each other. Thetight packing of the cubes 151 and the omission of additional packagingmaterial between the cubes significantly reduces packaging, storing, andshipping costs.

In another example, the frozen cannabis juice purée cubes 151 areloosely packed in a bag without vacuum sealing. Costs and packaging timeare substantially reduced by not vacuum sealing. Not all of the cubes151 contact a surface of the bag. Some of the cubes in the bag aresurrounded by other cubes and do not touch a surface of the bag. In yetanother example, the frozen cannabis juice purée cubes 151 are looselypacked in a plastic container having a lid. Not all of the cubes contacta surface of the plastic container. Depending on the size of thecontainer, the cubes may not contact the lid of the container.

FIG. 10A is a perspective diagram of frozen cannabis juice purée cubes151 having an amount of non-decarboxylated cannabinoids. The amount ofnon-decarboxylated cannabinoids comprises an amount oftetrahydrocannabinolic acid (THCa) and an amount of cannabidiolic acid(CBDa). The cubes 151 do not include any decarboxylated cannabinoids andthe cubes 151 are not psychoactive. Each of cubes 151 is a frozen cubeof one fluid ounce and has ten milligrams of THCa and fifteen milligramsof CBDa. The ratio of CBDa to THCa is 3:2. In other examples, eachfrozen structure has between 0.1 fluid ounce and 5.0 fluid ounces ofcannabis juice purée. Each cube comprises cannabis plant material thatincludes leaves, stems, flowers, or trichomes of the cannabis plant.Each cube can be modified to include or exclude non-cannabinoidcomponents of the cannabis plant such as terpenes, fatty acids,aminoacids, enzymes, vitamins, minerals, carotenoids, chlorophyll,flavonoids, and dietary fibers.

In the example of FIG. 10A, the amount of CBDa in each cube is greaterthan the amount of THCa. In other embodiments, each cube has ratio ofCBDa to THCa taken from the group consisting of: 2 CBDa to 1 THCa, 1CBDa to 1 THCa, 1 CBDa to 2 THCa, 1 CBDa to 3 THCa, 3 CBDa to 1 THCa, 0CBDa to 1 THCa (no CBDa, only THCa), and 1 CBDa to 0 THCa (no THCa, onlyCBDa). An artisan will appreciate that another combination ofcannabinoids (amount, type, or ratio) can be selected to form the cubesaccording to the type of ailment being targeted.

FIG. 10B is a perspective diagram of another embodiment of the frozenstructures where an amount of non-decarboxylated high concentratecannabis extract has been added to the cannabis juice purée prior tofreezing. High concentrate cannabis extract is also referred to as“kief”. The added amount of non-decarboxylated high concentrate cannabisextract substantially increases the amount of non-decarboxylatedcannabinoids in each cube. For example, in addition to the 25 milligramsof non-decarboxylated cannabinoids derived from the cannabis leaf, thereis an additional 500 milligrams of non-decarboxylated cannabinoids ineach cube derived from the added non-decarboxylated high concentratecannabis extract. The amount of cannabinoids from the non-decarboxylatedhigh concentrate cannabis extract is at least ten times the amount ofnon-decarboxylated cannabinoids from the raw cannabis plant. The highconcentrate cannabis extract is obtained through numerous processes andadded to the cubes, as explained below in connection with FIG. 10C.

FIG. 10C is a diagram of a female cannabis plant with flowers 165 havingtrichomes 164. The high concentrate cannabis extract is obtained bycollecting the trichomes 164 from many cannabis plants. The trichomes164 are typically present along an upper surface of a cannabis flower165. Each trichome has a stalk 166 and a gland head 167. Secretoryvesicles along the gland head 167 receive nutrients and turn them intocannabinoids. As flowering progresses, cannabinoids accumulate on anouter layer of the gland head 167. Generally, the greatest concentrationof cannabinoids in a cannabis plant is found in the trichomes 164. Thehigh concentrate cannabis extract is obtained by extracting thecannabinoids from the trichomes 164 of the cannabis plant. Highconcentrate cannabis extract is any material that has a greaterpercentage of cannabinoids per unit mass than cannabis in itsunprocessed and natural occurring state, such as in the leaves 168 orstem 169. The high concentrate cannabis extract is also referred to as“kief” or “high potency resin extract”.

Several techniques exist to obtain high concentrate cannabis extract. Afirst technique to obtain high concentrate cannabis extract involvessifting or tumbling raw cannabis flower material. The cannabis materialthat contains trichrome—the cannabinoid crystals—is generally present inthe cannabis flower material. Agitating and sifting the flower materialcauses the trichrome crystals to separate from the plant material. Byemploying this technique, the high concentrate cannabis extract willhave much higher percentage of cannabinoids per gram. It is not uncommonfor high concentrate cannabis extract to contain between 30% and 60%cannabinoids per gram. This could result in at least between 300milligrams and 600 milligrams of cannabinoids (THCa or CBDa) per gram ofhigh concentrate cannabis extract. When adding raw kief to frozencannabis juice purée cubes, each gram of high concentrate cannabisextract added to the cube can increase the amount of cannabinoids perounce of cube by between 300 milligrams and 600 milligrams.

A second type of high concentrate cannabis extract is obtained by usingCO₂ extraction, alcohol extraction, or other forms of high concentrateextraction using solvents or alcohols. High concentrate cannabis extractobtained through these other extractions methods may be obtained andadded to the frozen cannabis juice purée cubes prior to freezing orafter freezing. Such high concentrate extraction, when performed withhigh quality precision equipment, results in considerably highconcentrate cannabis extract or oils with almost undetectable amounts ofthe solvent remaining. If the resulting high concentrate cannabisextract are never heated (decarboxylated), these high concentratecannabis extract or oils can be added to the cannabis juice purée todramatically increase the amount of cannabinoids per cube.

In one example, while pouring the cannabis juice purée into the molds,an amount of high concentrate cannabis extract is weighed and added intoeach of the individual molds. For example, the cannabis juice purée isfilled to half the volume of the mold. Next, the high concentratecannabis extract is deposited into the half filled mold. Next, theremainder of the mold is filled with the cannabis juice purée. Thiswould maintain the high concentrate cannabis extract in a center of thefrozen cannabis juice purée cubes. In another example, while blendingthe raw cannabis material, high concentrate cannabis extract is added tothe entire cannabis juice purée. This is not as preferred, as some ofthe valuable high concentrate cannabis extract could be lost in theresidue on the side of the mixing or blending apparatus.

By adding high concentrate cannabis extract to the cubes, theconcentration of cannabinoids per cube can be increased to over 600 mgof cannabinoids per cube, if an entire gram of high concentrate cannabisextract were added per cube. In one specific embodiment, 500 milligramsof high concentrate cannabis extract is added in each cannabinoid cube.An artisan of ordinary skill will appreciate that employing highconcentrate cannabis extract allows for a completely ‘natural’ way toachieve very high cannabinoid potency per cube. In addition, there areno solvents or alcohol used to extract the high concentrate cannabisextract thereby reducing costs and production time and yields ‘foodgrade’ frozen cannabis juice purée cubes.

FIG. 10D is a table 170 showing various non-cannabinoid components andcannabinoid components that are obtainable from cannabis plant material.The left-side column of table 170 shows non-cannabinoid components thatcan be obtained from the cannabis plant. The non-cannabinoid componentsinclude terpenes, fatty acids, aminoacids, enzymes, vitamins, minerals,carotenoids, chlorophyll, flavonoids, and dietary fibers. The right-sidecolumn of table 170 shows cannabinoid components that can be obtainedfrom the cannabis plant. The cannabinoid components includecannabigerolic acid (CBGa), cannabigerovarin acid (CBGVA),tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin carboxylicacid (THCVA), cannadidiolic acid (CBDA), cannabidivarin acid (CBDVA),cannabichrome carboxylic acid (CBCA), cannabichrome varinic acid(CBCVA), tetrahydrocannabinol (THC), tetrahydrocannabidivarin (THCV),tetrahydrocannabivarin acid (THVA), cannabidiol (CBD), cannabidivarin(CBDV), cannabichromene (CBC), cannabichromevarin (CBCV), cannabigerol(CBG), cannabigerovarin (CBGV), cannabinerolic acid (CBNA),cannabigerovarinic acid (CBNVA), cannabinol (CBN), cannabicyclol (CBL),and cannabicyclol acid (CBLA).

FIG. 11 is a table 163 showing two general types of non-decarboxylatedcannabinoids, THCa and CBDa, along with their chemical names andstructural formulas. The non-decarboxylated cannabinoids include acarboxyl group (COOH).

FIG. 12 is a flowchart of a method 200 in accordance with a secondembodiment. The method 200 is a method of manufacturing and packaging aplurality of frozen structures of cannabis juice purée that comprises apre-determined amount of non-decarboxylated and decarboxylatedcannabinoids. The amount of decarboxylated cannabinoids in each frozenstructure is at least 5 mg. A structure with less than 5 mg is notconsidered to be a therapeutic dose of decarboxylated cannabinoidsbecause consuming less than 5 mg decarboxylated cannabinoids hasnegligible, if any, effects on the user. The amount of decarboxylatedcannabinoids may include one type of decarboxylated cannabinoid (such asCBD) or more than one type of decarboxylated cannabinoid (such as CBDand THC).

Non-decarboxylated cannabinoids exhibit therapeutic benefits withoutpsychoactive side effects. Decarboxylated cannabinoids also offertherapeutic benefits but may be considered psychoactive depending on theamount of THC present. Decarboxylated cannabinoids are typicallyproduced by heating raw cannabis material. By providing thepre-determined amount of non-decarboxylated cannabinoids anddecarboxylated cannabinoids in a single frozen structure, therapeuticresults in treating certain medical conditions are achieved.

In a first step (step 210), raw cannabis material is collected. Forexample, in FIG. 13, raw cannabis material 211 is collected from a firstcannabis plant 212 and a second cannabis plant 213. A first portion 214of the raw cannabis material 211 is obtained from the first cannabisplant 212. The first portion 214 has a first cannabinoid profile 215 of3 CBDa to 2 THCa. A second portion 216 of the raw cannabis material 211is obtained from the second cannabis plant 213. The second portion 216has a second cannabinoid profile 217 of 30 CBDa to 1 THCa. The secondportion 216 of the raw cannabis material 211 will eventually be heatedto obtain decarboxylated cannabinoids. At step 210, the first portion214 and second portion 216 in FIG. 13 are non-decarboxylated as both areraw cannabis material that has not been heated.

The amounts of non-decarboxylated and decarboxylated cannabinoids can becreated in unlimited combinations based on using different strains ofcannabis which have different ratios of THCa and CBDa. In this example,the second portion 216 has a second cannabinoid profile 217 differentfrom the first cannabinoid profile 215. In other embodiments, the firstportion 214 and the second portion 216 have the same cannabinoidprofile. Other cannabinoid profiles for the first portion include: 2CBDa to 1 THCa, 1 CBDa to 1 THCa, 1 CBDa to 2 THCa, 1 CBDa to 3 THCa, 3CBDa to 1 THCa, 0 CBDa to 1 THCa (no CBDa, only THCa), and 1 CBDa to 0THCa (no THCa, only CBDa). Other cannabinoid profiles for the secondportion include: 20 CBD to 1 THC, 10 CBD to 1 THC, or 5 CBD to 1 THC. Askilled artisan will appreciate that other cannabinoid profiles areobtainable.

In a second step (step 220), a non-decarboxylated cannabis juice puréeis formed from the first portion of collected raw cannabis material anda decarboxylated cannabis infusion is formed from the second portion ofcollected raw cannabis material. Forming the non-decarboxylated cannabisjuice purée does not involve heating the raw cannabis material. Forexample, in FIG. 14, the first portion of raw cannabis material 214 isblended in a blender 221 with water 222 and a thickening agent 223 toform a non-decarboxylated cannabis juice purée. In one example, 210.0grams of fresh cannabis leaves 214, 200.0 grams of banana 223, and 20.0ounces of filtered water 222 are combined in blender 221 and blendedtogether. The blender 221 is not a juicing machine. Both the cannabisplant material and the extracted cannabis juice remain in the blenderafter blending and become part of the resulting cannabis juice purée.The water 222 may be filtered water, unfiltered water, ice formed fromfiltered water, or ice formed from unfiltered water. The thickeningagent 223 aids in suspending the cannabis material yielding a moreuniform mixture than would be achieved without the thickening agent 223.The thickening agent 223 may be banana, avocado, psyllium husk, tapioca,corn starch, or any other food-grade thickener.

The cannabis juice purée is formed without a juicing process. In ajuicing process, a portion of the cannabis plant material is separatedfrom the juice of the cannabis plant. At least part of the separatedcannabis plant material is treated as waste and is disposed. To form thecannabis juice purée, however, all of the cannabis plant material isconverted into the cannabis juice purée. The resulting cannabis juicepurée includes all of the cannabis plant material placed in the blenderand all of the extracted cannabis juice that is extracted in theblending process. No waste product is generated in forming the cannabisjuice purée. Accordingly, the cannabis juice purée has all of thecannabis plant material and is rich in dietary fibers andnon-cannabinoid components that include terpenes, fatty acids,aminoacids, enzymes, vitamins, minerals, carotenoids, chlorophyll,flavonoids, and dietary fibers.

Forming the decarboxylated cannabis infusion involves heating the secondportion of collected raw cannabis material. For example, in FIG. 15, thesecond portion of raw cannabis material 216 is heated along with fattyoil 224 in a heating mechanism 225. A typical ratio is one ounce ofdried cannabis flower mixed with six cups of olive or coconut oil and isheated in a heating mechanism 225 for one to eight hours to create thedecarboxylated cannabis infusion. The heating mechanism 225 shown inFIG. 15 is a crock pot.

In another example, the decarboxylated cannabinoid is generated byheating dried cannabis flower in an oven without oil. For example, thedried cannabis flower is heated in an oven at 240° F. for thirty toforty minutes. Other conventional methods for generating decarboxylatedcannabis may be employed.

In a third step (step 230), the non-decarboxylated cannabis juice puréeand the decarboxylated cannabis infusion are deposited into molds of atray such that each mold has non-decarboxylated and decarboxylatedcannabinoids. The tray has a plurality of molds each having asubstantially identical size, shape, and volume. Depositing the cannabisjuice purée and cannabis infusion into similar molds results in eachcube having a substantially similar cannabinoid profile. For example, inFIG. 16, the non-decarboxylated cannabis juice purée 231 and thedecarboxylated cannabis infusion 234 are deposited into molds 232 of atray 233. First, the non-decarboxylated cannabis juice purée 231 isdeposited into each mold 232 to fill approximately half of the mold 232.Next, the decarboxylated cannabis infusion 234 is deposited at a centerlocation on the top surface of the half-filled mold. In this example, ameasuring syringe 235 is employed to deposit a particular amountdecarboxylated cannabis infusion 234 into the molds 232. Next, thenon-decarboxylated cannabis juice purée 231 is deposited into each moldabove the layer of decarboxylated cannabis infusion 234 to fill the restof each mold 232.

In the embodiment of FIG. 16, the tray 233 has fifteen cubic shapedmolds that each holds one fluid ounce. The size, shape, and volume ofeach mold and the number of molds on the tray are selected depending onthe desired size of the frozen cannabis juice purée cubes and amount ofcannabinoids to be delivered in each dose.

In another example, the decarboxylated cannabis infusion is depositeddirectly into the non-decarboxylated cannabis juice purée 231 in theblender 221 of FIG. 14. The resulting mixture has generally uniformdistribution of decarboxylated cannabinoids and non-decarboxylatedcannabinoids that is deposited into the molds of the tray. No syringe235 is needed using this technique.

In a fourth step (step 240), the tray of molds having the cannabis juicepurée and decarboxylated cannabis infusion are frozen to form frozencannabis juice purée cubes having non-decarboxylated cannabinoids anddecarboxylated cannabinoids. For example, in FIG. 17, the tray 233having the non-decarboxylated cannabis juice purée 231 and thedecarboxylated cannabis infusion 234 is placed in a freezer 242 so thatthe non-decarboxylated cannabis juice purée 231 and the decarboxylatedcannabis infusion 234 in each mold 232 of tray 233 can freeze. Thetemperature within freezer 242 is typically between 0.0° F. and 5.0° F.,but may be less than 0.0° F. Freezing the cannabis juice purée promotespreservation because harvested raw cannabis material is not acceptablefor consumption after three days, even when the cannabis material isstored in a refrigerator. However, by freezing the cannabis juice puréeto form frozen cannabis juice purée cubes, the shelf-life is extendedfor at least six months if the frozen cannabis juice purée cubes areproperly stored in a freezer.

In a fifth step (step 250), the cubes having non-decarboxylatedcannabinoids and decarboxylated cannabinoids are packaged into apackage. The frozen cannabis juice purée cubes are packaged in a vacuumsealed package, a bag, or a container having a detachable lid. Forexample, in FIG. 18, the frozen cannabis juice purée cubes 251 areremoved from the molds 232 of the tray 233 and are placed on vacuumsealed bag 252. The vacuum sealed bag 252 is sealed by vacuum sealingmachine 253 to form a vacuum sealed package having the frozen cannabisjuice purée cubes 251.

FIG. 19 is a perspective diagram of a package 254 with the frozencannabis juice purée cubes 251. The frozen cannabis juice purée cubes251 have non-decarboxylated cannabinoids and decarboxylatedcannabinoids. The package 254 delivers the frozen cannabis juice puréecubes 251 cheaply because the only packaging material involved is thevacuum sealed bag 252. The package 254 provides for optimal storing,packing, and transporting because the packages are rectangular or squareand have flat surfaces that allow the packages to be stacked above eachother. The frozen cannabis juice purée cubes 251 consume over 95% of thetotal volume of package 254 allowing for maximum delivery of frozencannabis juice purée cubes per shipment of packages.

FIG. 20 is a side view of the package 254 with the frozen cannabis juicepurée cubes 251. The package 254 has an upper portion 255 and a lowerportion 256. Each of the cubes 251 has an upper surface 257 and a lowersurface 258. Each upper surface 257 of the cubes contacts the upperportion 255 of the package 254 and each lower surface 258 of the cubes251 contacts a lower portion 256 of the package 254. No packagingmaterial is disposed within the package.

FIG. 21 is top view of the package 254 with the frozen cannabis juicepurée cubes 251. The frozen cannabis juice purée cubes 251 are packagedin an array formation. Each of the frozen cannabis juice purée cubes 251has a substantially identical shape and each cube is adjacent to atleast one other cube. Reference numeral 259 identifies a surface of onecube adjacent to a surface of another of the cubes. Each frozen cannabisjuice purée cube has at least two surfaces that are adjacent to surfacesof at least two other cubes.

Reference numeral 260 identifies a frozen cannabis juice purée cubealong a corner of the array of cubes 251 having a first surface that isadjacent to a surface of a second cube and a second surface that isadjacent to a surface of a third cube. Cube 260 has two surfaces each ofwhich contacts a surface of one of two other cubes. Reference numeral261 identifies a frozen cannabis juice purée cube along an edge of thearray of cubes 251 having a first surface that is adjacent to a surfaceof a second cube, a second surface that is adjacent to a surface of athird cube, and a third surface that is adjacent to a surface of afourth cube. Cube 261 has three surfaces each of which contacts asurface of one of three other cubes. Reference numeral 262 identifies afrozen cannabis juice purée cube at an inner portion of the array ofcubes 251 having a first surface that is adjacent to a surface of asecond cube, a second surface that is adjacent to a surface of a thirdcube, a third surface that is adjacent to a surface of a fourth cube,and a fourth surface that is adjacent to a surface of a fifth cube. Cube262 has four surfaces each of which contacts a surface of one of fourother cubes.

In accordance with at least one novel aspect, the frozen cannabis juicepurée cubes 251 are not contained in separate containers. No packagingmaterial is present between the frozen cannabis juice purée cubes 251.Although a gap is shown between the cubes 251, some or all of the cubes251 may be directly contacting each other. The tight packing of thecubes 251 significantly reduces packaging, storing, and shipping costs.

In another example, the frozen cannabis juice purée cubes 251 areloosely packed in a bag without vacuum sealing. Costs and packaging timeare substantially reduced by not vacuum sealing. Not all of the cubescontact a surface of the bag. Some of the cubes in the bag aresurrounded by other cubes and do not touch a surface of the bag. In yetanother example, the frozen cannabis juice purée cubes 251 are looselypacked in a plastic container having a lid. Not all of the cubes contacta surface of the plastic container. Depending on the size of thecontainer, the cubes may not contact the lid of the container.

FIG. 22A is a perspective diagram of frozen cannabis juice purée cubes251 having an amount of non-decarboxylated cannabinoids and an amount ofdecarboxylated cannabinoids. The amount of non-decarboxylatedcannabinoids comprises an amount of tetrahydrocannabinolic acid (THCa)and an amount of cannabidiolic acid (CBDa). The amount of decarboxylatedcannabinoids comprises an amount of tetrahydrocannabinol (THC) and anamount of cannabidiol (CBD). Each of cubes 251 is a frozen cube of onefluid ounce and has 10 mg of THCa, 1 mg of THC, 15 mg of CBDa, and 30 mgof CBD. In this example, the ratio of CBDa to THCa is 3:2 and the ratioof CBD to THC is 30:1. The amount of CBDa in each cube is greater thanthe amount of THCa, and the amount of CBD in each cube is greater thanthe amount of THC. The frozen cannabis juice purée cubes may be made toinclude or exclude non-cannabinoid components that include terpenes,fatty acids, aminoacids, enzymes, vitamins, minerals, carotenoids,chlorophyll, flavonoids, and dietary fibers.

FIG. 22B is a perspective diagram of another embodiment of frozenstructures of cannabis juice purée having decarboxylated cannabisinfusion and non-decarboxylated high concentrate cannabis extract. Inthe example of FIG. 22B, the frozen structures have 25 mg ofnon-decarboxylated cannabinoids from raw cannabis plant, 31 mg ofdecarboxylated cannabinoids from decarboxylated cannabis infusion, 500mg of non-decarboxylated cannabinoids from non-decarboxylated highconcentrate cannabis extract. The added amount of non-decarboxylatedhigh concentrate cannabis extract substantially increases the amount ofcannabinoids in each frozen structure. In this example, thenon-decarboxylated high concentrate cannabis extract adds an additional500 mg of non-decarboxylated cannabinoids in each structure. The amountof non-decarboxylated cannabinoids from the non-decarboxylated highconcentrate cannabis extract is at least ten times the amount ofnon-decarboxylated cannabinoids derived from the raw cannabis plant. Thehigh concentrate cannabis extract is obtained through numerous processesand included in the frozen structures as explained above in connectionwith FIG. 10B.

FIG. 22C is a perspective diagram of another embodiment of frozenstructures of cannabis juice purée having decarboxylated highconcentrate cannabis extract. In the example of FIG. 22C, the frozenstructures have 25 mg of non-decarboxylated cannabinoids from rawcannabis plant and 105 mg of decarboxylated cannabinoids fromdecarboxylated high concentrate cannabis extract. The added amount ofdecarboxylated high concentrate cannabis extract substantially increasesthe amount of cannabinoids in each frozen structure. In this example,the decarboxylated high concentrate cannabis extract adds an additional105 mg of decarboxylated cannabinoids to each structure. Thedecarboxylated high concentrate cannabis extract is obtained by heatingthe high concentrate cannabis extract obtained through numerousprocesses described above in connection with FIG. 10B. A few techniquesare described below.

The high concentrate cannabis extract is decarboxylated by first heatingthe non-decarboxylated high concentrate cannabis extract on a dish in anoven at temperatures between 212° F. and 340° F. The high concentratecannabis extract becomes decarboxylated as a result of heating thusconverting the THCa and CBDa to THC and CBD, respectively, as well asother decarboxylated cannabinoids. This results in a substantially highpotency of THC and CBD, for example, approximately 30% and 60%decarboxylated cannabinoids per gram. In a second technique, thecannabis flower and flower trim can also be decarboxylated in an oven attemperatures between 212° F. and 340° F. This would result in plantmaterial being decarboxylated at between about 10% and 30%decarboxylated cannabinoids per gram. The percentage yield in thistechnique is less due to plant material. In a third technique, the highconcentrate cannabis extract or cannabis flower can also be added to afood grade oil mixture and heated to between 212° F. and 340° F. Suchfood grade oil mixture is selected from the group consisting of oliveoil, coconut oil, avocado oil, or similar cooking oil. A crockpot orpressure cooker can be employed to heat the oils. The result of thistechnique is an infused oil that contains decarboxylated cannabinoidscomprising between 100 mg and 300 mg of cannabinoids per fluid ounce.

To incorporate the decarboxylated high concentrate cannabis into thefrozen structures, several techniques may be employed. In one example,while pouring the cannabis juice purée into the molds, an amount ofdecarboxylated high concentrate cannabis extract is weighed and addedinto each of the individual molds. For example, the cannabis juice puréeis filled to half the volume of the mold. Next, the decarboxylated highconcentrate cannabis extract is deposited. Next, the remainder of themold is filled with the cannabis juice purée. This would maintain thedecarboxylated high concentrate cannabis extract within a center of thefrozen frozen cannabis juice purée cubes. In another example, whileblending the raw cannabis material, decarboxylated high concentratecannabis extract is added to the entire cannabis juice purée. Theresulting cannabis juice purée would have a uniform amount of thedecarboxylated high concentrate cannabis extract. This is not aspreferred, as some of the valuable decarboxylated high concentratecannabis extract could be lost in the residue on the side of the mixingor blending apparatus. Depending on the potency desired, any amount ofdecarboxylated high concentrate cannabis extract can be added to thecannabis juice purée.

The amounts and types of cannabinoids varies and is selected accordingto the desired potency and amount desired. For example,non-decarboxylated frozen cannabis juice purée cubes that do not havethe high concentrate cannabis extract range between 5 mg and 200 mg ofnon-decarboxylated cannabinoid per fluid ounce of cube.Non-decarboxylated frozen cannabis juice purée cubes that do have thehigh concentrate cannabis extract range between 5 mg and 2,500 mg ofnon-decarboxylated cannabinoid per fluid ounce of cube. Decarboxylatedfrozen cannabis juice purée cubes that have the high concentratecannabis extract range between 5 mg and 2,500 mg of non-decarboxylatedcannabinoids per fluid ounce of cube and between 5 mg and 2,500 mg ofdecarboxylated cannabinoids per fluid ounce of cube. Decarboxylatedfrozen cannabis juice purée cubes that have the decarboxylated oil orflower described above range between 5 mg and 2,500 mg ofnon-decarboxylated cannabinoids per fluid ounce of cube and between 5 mgand 2,500 mg of decarboxylated cannabinoids per fluid ounce of cube.

FIG. 22D is a perspective diagram of another embodiment of frozenstructures of cannabis juice purée having decarboxylated highconcentrate cannabis extract and non-decarboxylated high concentratecannabis extract. In the example of FIG. 22D, the frozen structures have25 mg of non-decarboxylated cannabinoids from raw cannabis plant, 105 mgof decarboxylated cannabinoids from decarboxylated high concentratecannabis extract, and 500 mg of non-decarboxylated cannabinoids fromnon-decarboxylated high concentrate cannabis extract.

FIG. 23 is a table 263 showing two general types of decarboxylatedcannabinoids, THC and CBD, along with their chemical names andstructural formulas. The decarboxylated cannabinoids are formed througha decarboxylation process that removes the carboxyl group (COOH).

FIG. 24 is a flowchart of a method 300 in accordance with another novelaspect. In a first step (step 310), a plurality of packages havingfrozen structures of cannabis juice purée is stored. For example, inFIG. 25, a plurality of packages 311 is stored in a freezer 312. Thepackages are 311 are stored by stacking each package above anotherpackage. For example, package 313 is disposed above package 314. Package315 is to be placed above package 313. Each of the packages comprises aplurality of frozen cannabis juice purée cubes 316. At least one of thefrozen cannabis juice purée cubes contacts the package. Each package hasat least two flat surfaces due to the uniform size and shape of eachcube 316. Accordingly, the packages 311 stack compactly in the freezer312. If, on the other hand, the cubes within in each package were notuniform in size and shape, then the packages would not have flatsurfaces adapted for stacking. Additionally, by not placing each cube ina separate package and by not including any additional packagingmaterials between the package 315 and each cube 316, each packageconsumes minimal space in freezer 312 thereby increasing the number ofpackages that can be stored per unit volume of storage capacity.

FIG. 26 is a perspective diagram of a tray 400 having a plurality ofmolds 401. All of the molds 401 have a substantially identical structurethereby yielding cubes having a consistent size and dosage ofcannabinoids. In this example, each mold is cubic shaped and holds onefluid ounce. In other embodiments, the molds may be smaller or largerdepending on the desired size of the cubes. The volume of each mold 401is typically between 0.125 cubic inches (0.5 inches×0.5 inches×0.5inches) and 8.0 cubic inches (2.0 inches×2.0 inches×2.0 inches). Anartisan of ordinary skill appreciates that the molds may be larger orshaped differently. Other trays may be selected that frozen structuresof cannabis juice purée of between 0.1 fluid ounce and 5.0 fluid ouncesof cannabis juice purée.

FIG. 27 is a top view of the tray 400 having a plurality of molds 401.

Other frozen structures of cannabis juice purée may be formed havingdifferent shapes. FIGS. 28-36 show how the frozen structures may beformed into various other shapes that are non-cubic.

FIG. 28 is a top view of a tray 403 having a plurality of cylindricalshaped molds.

FIG. 29 is a top view of a tray 404 having a plurality of rectangularshaped molds.

FIG. 30 is a top view of a tray 405 having a plurality of hexagonalshaped molds.

FIG. 31 is a top view of a tray 406 having a plurality of triangularshaped molds.

FIG. 32 is a top view of a tray 407 having a plurality of star shapedmolds.

FIG. 33 is a top view of a tray 408 having a plurality of trapezoidalshaped molds.

FIG. 34 is a top view of a tray 409 having a plurality of concave shapedmolds.

FIG. 35 is a top view of a tray 410 having a plurality of parallelogramshaped molds.

FIG. 36 is a top view of a tray 411 having a plurality of leaf shapedmolds.

FIG. 37 is a diagram of a conventional coconut milk based cannabis icecream 420. The coconut milk based cannabis ice cream 420 is packaged ina container 421 having a lid 422. The conventional coconut milk basedcannabis ice cream 420 is available from Ohana Farms at(http://www.ohanaedu.org/index.php/products/cbd-cubes/). Theconventional coconut milk based cannabis ice cream 420 has a soft,ice-cream texture and requires separate packaging for each dose of icecream 420.

FIG. 38 is a diagram showing how the container 421 is placed onto acontainer holder 423. The container holder 423 includes a retaineropening 424 into which the container 421 is placed. The container holder423 includes six retainer openings and holds up to six of the containers421.

FIG. 39 is a diagram showing how the container holder 423 having sixcontainers is placed into a package 425. The container holder 423 havingthe six containers is inserted via opening 426. After the containerholder 423 having the six containers is inside the package 425, thepackage 425 is sealed.

FIG. 40 is a diagram of the package 425 containing the container holder423 having the six containers with coconut milk based cannabis icecreams.

FIG. 41 is a table 500 showing the advantages of novel package 154(shown in FIG. 7) and novel package 254 (shown in FIG. 19) over theconventional package 425 shown in FIG. 40. The novel packages 154 and254 exhibit advantages with respect to storage capacity, packagingcosts, waste generation, and quantity of cubes per package.

The novel packages 154 and 254 utilize minimal storage capacity ascompared to the conventional package 425. The novel packages 154 and 254have at least two flat surfaces allowing several of the novel packages154 and 254 to be stacked above each other. The conventional package425, on the other hand, does not have flat surfaces and does not providean advantageous utilization of storage space.

The novel packages 154 and 254 involve minimal packaging costs ascompared to the conventional package 425. The only packaging involved isthe vacuum seal bag, resealable bag, or container in which the novelcubes are stored. At least one of the frozen cannabis juice purée cubescontacts the package. No additional packaging is inserted between thecubes. No additional packaging is inserted between the cubes and theouter package. The conventional package 425, on the other hand, hassubstantial packaging. For example, each cannabinoid structure isindividually packaged in a separate container and covered with a lid. Inaddition, each of the individual containers is then placed onto aholder. Therefore, the conventional package 425 has significantlygreater packaging costs than the novel packages 154 and 254.

The novel packages 154 and 254 generate minimal waste as compared to theconventional package 425. The novel packages 154 and 254 only generatewaste from a single package, such as a bag, vacuum sealed bag, orcontainer. The novel packages 154 and 254 may have a label disposed onan outer surface, but no other waste is generated because the entirecontents of the novel packages 154 and 254 are consumed. Theconventional package 425, on the other hand, generates substantial wasteas compared to the novel packages 154 and 254 because of all of thepackaging, including six containers, six lids, the container holder, andthe outer packaging.

The novel packages 154 and 254 deliver significantly more cannabinoidsper unit volume of packaging as compared to the conventional package425. A single one of the novel packages 154 and 254 delivers twentycubes due, in part, to the minimal packaging involved. The conventionalpackage 425, on the other hand, only carries six coconut milk basedcannabis ice creams.

FIG. 42 is a flowchart of a method 600 in accordance with a thirdembodiment. The method 600 is a method of manufacturing and packaging afrozen ice pop of cannabis juice purée. In one specific embodiment, thepackaged frozen ice pop of cannabis juice purée has an amount ofnon-decarboxylated cannabinoids and is non-psychoactive. In anotherspecific embodiment, the packaged frozen ice pops of cannabis juicepurée has an amount of non-decarboxylated cannabinoids and an amount ofdecarboxylated cannabinoids. The amount of decarboxylated cannabinoidsin each ice pop is at least 5 mg. Decarboxylated cannabis infusion,non-decarboxylated high concentrate cannabis extract, or decarboxylatedhigh concentrate cannabis extract are optionally added to the frozen icepops of cannabis juice purée.

In a first step (step 610), a cannabis juice purée is formed. To form afrozen ice pop of cannabis juice purée that is non-psychoactive, rawcannabis material having an amount of non-decarboxylated cannabinoids iscollected. For example, in FIG. 2, raw cannabis material 112 iscollected by trimming leaves 113 from the cannabis plant 111, and inFIG. 3, the raw cannabis material 112 is blended in a blender 121 withwater 122 and a thickening agent 123 to form a cannabis juice purée.

To form a packaged frozen ice pop of cannabis juice purée that hasdecarboxylated cannabinoids, a portion of the collected raw cannabismaterial is heated. For example, in FIG. 13, raw cannabis material 211is collected from a first cannabis plant 212 and a second cannabis plant213. A first portion 214 of the raw cannabis material 211 is obtainedfrom the first cannabis plant 212. Next, the first portion of rawcannabis material 214 is blended in a blender 221 with water 222 and athickening agent 223 to form a non-decarboxylated cannabis juice puréeas shown in FIG. 14. Next, a second portion 216 of the raw cannabismaterial 211 is obtained from the second cannabis plant 213 as shown inFIG. 13. Next, the second portion of collected raw cannabis material isheated to form a decarboxylated cannabis infusion, as shown for examplein FIG. 15. The non-decarboxylated cannabis juice purée anddecarboxylated cannabis infusion are combined prior to freezing.

In both the non-decarboxylated and decarboxylated embodiments of thepackaged frozen ice pop of cannabis juice purée, a sweetening agent isoptionally added to the cannabis juice purée. The sweetening agent isselected from the group consisting of honey, stevia, fruit juice, sugar,corn syrup, or any other type of food grade sweetener. The sweeteningagent provides a frozen ice pop of cannabis juice purée that is morepalatable than if the sweetening agent were not included. Flavoringagents are optionally added to the packaged cannabis juice purée, suchas fruit flavor, spice (apple, cherry, mint, tart, etc.), or any othertype of food grade flavoring. Fruit juice, fruit, or vegetable materialmay also be added, such as blueberries, blueberry juice, carrots, orcarrot juice.

In a second step (step 620), the cannabis juice purée is deposited intoa container. In one example, the container is a tube shaped containermade of a flexible material. For example, in FIG. 43, the cannabis juicepurée 621 is deposited into container 622 through opening 623. Thecontainer 622 is a tube shaped container formed from a thermoplasticpolymer such as polypropylene plastic resin. In one example, the opening623 of the container 622 is resealable. The container 622 with theresealable opening 623 is available from the following internet address:http://zipzicles.com/. In one example, the opening 623 of the container622 is not resealable and is permanently sealed after the cannabis juicepurée 621 is deposited into the container 622.

In a third step (step 630), the container having the cannabis juicepurée to form a packaged frozen ice pop of cannabis juice purée. Forexample, in FIG. 44 the container 622 having the cannabis juice purée621 is placed in a freezer 631 so that the cannabis juice purée 621 inthe container 622 can freeze. The temperature within freezer 631 istypically between 0.0° F. and 5.0° F., but may be less than 0.0° F.Freezing the cannabis juice purée promotes preservation becauseharvested raw cannabis material is not acceptable for consumption afterthree days, even when the cannabis material is stored in a refrigerator.However, by freezing the cannabis juice purée to form the packagedfrozen ice pop of cannabis juice purée, the shelf-life is extended forat least six months if properly stored in a freezer.

FIG. 45A is a perspective diagram of the packaged frozen ice pop ofcannabis juice purée 632 with only non-decarboxylated cannabinoids. Thefrozen ice pop of cannabis juice purée 632 has a cannabinoid profile633. The packaged frozen ice pop of cannabis juice purée 632 is formedby carrying out the steps set forth in method 600 such that the cannabisjuice purée in the first step (step 610) has only raw, blended cannabismaterial. None of the collected cannabis material is heated. Thepackaged frozen ice pop of cannabis juice purée 632 does not include anydecarboxylated cannabinoids and the packaged frozen ice pop of cannabisjuice purée 632 is not psychoactive. In this example, frozen ice pop ofcannabis juice purée 632 has 30 mg of THCa per 3 fluid ounces and 45 mgof CBDa per 3 fluid ounces. The ratio of CBDa to THCa is 3:2. The amountof CBDa in each ice pop is greater than the amount of THCa, and theamount of CBD in each ice pop is greater than the amount of THC. Inother embodiments, each ice pop has ratio of CBDa to THCa taken from thegroup consisting of: 2 CBDa to 1 THCa, 1 CBDa to 1 THCa, 1 CBDa to 2THCa, 1 CBDa to 3 THCa, 3 CBDa to 1 THCa, 0 CBDa to 1 THCa (no CBDa,only THCa), and 1 CBDa to 0 THCa (no THCa, only CBDa). The frozen icepop of cannabis juice purée may be made to include or excludenon-cannabinoid components of the cannabis plant that include terpenes,fatty acids, aminoacids, enzymes, vitamins, minerals, carotenoids,chlorophyll, flavonoids, and dietary fibers. In yet other embodiments,the frozen ice pop of cannabis juice purée has between 1 mg and 500 mgof THCa and between 1 mg and 500 mg of CBDa. Non-decarboxylated highconcentrate cannabis extract may also be added to the frozen ice pop ofcannabis juice purée to achieve high concentrations ofnon-decarboxylated cannabinoids.

FIG. 45B is a perspective diagram of another embodiment of a packagedfrozen ice pop of cannabis juice purée with added non-decarboxylatedhigh concentrate cannabis extract. In the example of FIG. 45B, thepackaged frozen ice pop of cannabis juice purée has 75 mg ofnon-decarboxylated cannabinoids from raw cannabis plant and 1,500 mg ofnon-decarboxylated cannabinoids from non-decarboxylated high concentratecannabis extract.

FIG. 46A is a perspective diagram of a packaged frozen ice pop ofcannabis juice purée 634 with added decarboxylated cannabinoids. Thepackaged frozen ice pop of cannabis juice purée 634 is formed bycarrying out the steps set forth in method 600 such that the cannabisjuice purée in the first step (step 610) has raw, blended cannabismaterial in addition to decarboxylated cannabis infusion. The packagedfrozen ice pop of cannabis juice purée 634 includes non-decarboxylatedcannabinoids and decarboxylated cannabinoids. In this example, packagedfrozen ice pop of cannabis juice purée 634 has 75 mg ofnon-decarboxylated cannabinoids from raw cannabis plant and 95 mg ofdecarboxylated cannabinoids from decarboxylated cannabis infusion.

FIG. 46B is a perspective diagram of another embodiment of a packagedfrozen ice pop of cannabis juice purée with added decarboxylatedcannabis infusion and non-decarboxylated high concentrate cannabisextract. In the example of FIG. 46B, the packaged frozen ice pop ofcannabis juice purée has 75 mg of non-decarboxylated cannabinoids fromraw cannabis plant, 95 mg of decarboxylated cannabinoids fromdecarboxylated cannabis infusion, and 1,500 mg of non-decarboxylatedcannabinoids from non-decarboxylated high concentrate cannabis extract.

FIG. 46C is a perspective diagram of another embodiment of a packagedfrozen ice pop of cannabis juice purée with added decarboxylated highconcentrate cannabis extract. In the example of FIG. 46C, the packagedfrozen ice pop of cannabis juice purée has 75 mg of non-decarboxylatedcannabinoids from raw cannabis plant and 310 mg of decarboxylatedcannabinoids from decarboxylated high concentrate cannabis extract.

FIG. 46D is a perspective diagram of another embodiment of a packagedfrozen ice pop of cannabis juice purée with added decarboxylated highconcentrate cannabis extract and non-decarboxylated high concentratecannabis extract. In the example of FIG. 46D, the packaged frozen icepop of cannabis juice purée has 75 mg of non-decarboxylated cannabinoidsfrom raw cannabis plant, 310 mg of decarboxylated cannabinoids fromdecarboxylated high concentrate cannabis extract, and 1,500 mg ofnon-decarboxylated cannabinoids from non-decarboxylated high concentratecannabis extract.

FIG. 47 is a diagram of a user 635 consuming the packaged frozen ice popof cannabis juice purée 632/634. The user 635 opens the top of thecontainer 622 thereby forming an opening 623. The frozen ice pop ofcannabis juice purée 636 passes through the opening for the user 635 toconsume. In this example the opening 623 is resealable such that theuser 635 can consume a portion of the packaged frozen ice pop ofcannabis juice purée 632/634, reseal the top, and store the partiallyconsumed packaged frozen ice pop of cannabis juice purée 632/634 in afreezer for future consumption.

FIG. 48 is a diagram of a side view of the packaged frozen ice pop ofcannabis juice purée 632/634. The container 622 has an upper extent 637,a lower extent 638, a first side extent 639, and a second side extent640. The frozen ice pop of cannabis juice purée 636 is disposed withinan inner portion 641. The frozen ice pop of cannabis juice purée 636directly contacts the inner portion 641 of container 622. No packagingmaterial is disposed between the frozen ice pop of cannabis juice purée636 and the inner portion 641 of container 622. The packaged frozen icepop of cannabis juice purée 632/634 includes a resealable mechanism 642.The resealable mechanism 642 is similar to the resealable mechanismsprovided in zipper storage bags or slider storage bags.

In this example, the packaged frozen ice pop of cannabis juice purée632/634 is between 1.0 to 2.0 inches wide (dimension of upper and lowerextents 637/638) and between 7.0 and 9.0 inches long (dimension of sideextents 639/640). Each of the first and second side extents 639 and 640is at least three times a length of each of the upper and lower extents637 and 638. The upper extent 637 extends parallel to the lower extent638. The first side extent 639 extends parallel to the second sideextents 640. The packaged frozen ice pop of cannabis juice purée 632/634has a rectangular shaped when viewed from the side perspective of FIG.48.

FIG. 49 is a diagram of a top view of the packaged frozen ice pop ofcannabis juice purée 632/634. The packaged frozen ice pop of cannabisjuice purée 632/634 has an edge portion 643 having a first thickness644. The packaged frozen ice pop of cannabis juice purée 632/634 has acenter portion 645 having a second thickness 646. The second thickness646 is at least ten times the first thickness 644. The packaged frozenice pop of cannabis juice purée 632/634 has an oval shape when viewedfrom the top perspective of FIG. 49.

FIG. 50 is a diagram of a side view of another embodiment of a packagedfrozen ice pop of cannabis juice purée 650 having a container 651 thatis not resealable. A frozen ice pop of cannabis juice purée 652 isdisposed within container 651. The packaged frozen ice pop of cannabisjuice purée 650 has a top portion 653 that does not include a resealablemechanism as in the packaged frozen ice pop of cannabis juice purée632/634 shown in FIG. 47. A user tears the top portion 653 of thecontainer 651 to provide an opening so that the frozen ice pop ofcannabis juice purée 652 passes through the opening and is consumed bythe user.

FIG. 51 is a flowchart of a method 700 to package a plurality ofpackaged frozen ice pops of cannabis juice purée. In a first step (step710), a plurality of packaged frozen ice pops of cannabis juice purée ispackaged into a container. For example, in FIG. 52, a plurality ofpackaged frozen ice pops of cannabis juice purée 711 is placed inside apackage 712. The plurality of packaged frozen ice pops of cannabis juicepurée 711 is disposed within the package 712. An amount of instructionsis included with the package. In one example, the amount of instructionsis provided on a label 713 affixed or printed directly onto the packageand instructs the user on the types and amounts of cannabinoids presentin each frozen ice pop of cannabis juice purée. In another example, alabel is also printed or affixed onto each of the plurality of packagedfrozen ice pops of cannabis juice purée 711. The amount of instructionsmay also instruct a user on how to consume the frozen ice pop ofcannabis juice purée as well as provide information regarding healthbenefits and possible side effects.

FIG. 53 is a flowchart of a method 800 to store packages comprising aplurality of packaged frozen ice pops of cannabis juice purée. Forexample, in a first step (step 810), a plurality of packaged frozen icepops of cannabis juice purée are stored at a temperature that preventsthe packaged frozen ice pops of cannabis juice purée from melting. Forexample, in FIG. 54, a plurality of packages 811 is stored in a freezer812. The packages 811 are stored by arranging each package in acompartment of the freezer 812. The stored packages 813 are stored untilthey are to be distributed to dispensaries or users.

FIG. 55 is a flowchart of a method 900 in accordance with a fourthembodiment. The method 900 is a method of manufacturing and packaging acannabis juice purée. In one specific embodiment, the packaged cannabisjuice purée has an amount of non-decarboxylated cannabinoids and isnon-psychoactive. In another specific embodiment, the packaged cannabisjuice purée has an amount of non-decarboxylated cannabinoids and anamount of decarboxylated cannabinoids. The amount of decarboxylatedcannabinoids in each packaged cannabis juice purée is at least 5 mg. Thepackaged cannabis juice purée is not frozen and can be stored at roomtemperature or in a refrigerator until opened.

In a first step (step 910), a cannabis juice purée is formed. To form apackaged cannabis juice purée that is non-psychoactive, raw cannabismaterial having an amount of non-decarboxylated cannabinoids iscollected. For example, in FIG. 2, raw cannabis material 112 iscollected by trimming leaves 113 from the cannabis plant 111, and inFIG. 3, the raw cannabis material 112 is blended in a blender 121 withwater 122 and a thickening agent 123 to form a cannabis juice purée.

To form a packaged cannabis juice purée that is psychoactive, a portionof the collected raw cannabis material is heated. For example, in FIG.13, raw cannabis material 211 is collected from a first cannabis plant212 and a second cannabis plant 213. A first portion 214 of the rawcannabis material 211 is obtained from the first cannabis plant 212.Next, the first portion of raw cannabis material 214 is blended in ablender 221 with water 222 and a thickening agent 223 to form anon-decarboxylated cannabis juice purée as shown in FIG. 14. Next, asecond portion 216 of the raw cannabis material 211 is obtained from thesecond cannabis plant 213 as shown in FIG. 13. Next, the second portionof collected raw cannabis material is heated, as shown for example inFIG. 15. The non-decarboxylated cannabis juice purée is combined withthe decarboxylated cannabis juice purée prior to packaging.

In both the non-decarboxylated embodiment and the decarboxylatedembodiment of the packaged cannabis juice purée, a sweetening agent orflavoring agent is optionally added to the cannabis juice purée. Thesweetening agent is selected from the group consisting of honey, stevia,fruit juice, sugar, corn syrup, or any other type of food gradesweetener. The sweetening agent provides a cannabinoid juice blend thatis more palatable than if the sweetening agent were not included.Flavoring agents are optionally added to the packaged cannabis juicepurée, such as fruit flavor, spice (apple, cherry, mint, tart, etc.), orany other type of food grade flavoring. Fruit juice, fruit, or vegetablematerial may also be added, such as blueberries, blueberry juice,carrots, or carrot juice.

In a second step (step 920), the cannabis juice purée is deposited intoa container. In one example, the container is a cylindrical shapedstructure having a lid. The container 921 is formed from a glassmaterial, a plastic material, or a paper-based material. For example, inFIG. 56, the cannabis juice purée 921 is deposited into a container 922through opening 923.

In a third step (step 930), the container having the cannabis juicepurée is packaged without heating the cannabis juice purée. For example,in FIG. 57, the cannabis juice purée 921 is packaged using high pressureprocessing (HPP) without applying heat thereby preventing the cannabisjuice purée 921 from decarboxylating during the packaging process.Conventional pasteurization methods, on the other hand, apply heat whichmay undesirably decarboxylate the cannabinoids in the cannabis juicepurée.

During the HPP process, the cannabis juice purée 921 is loaded into ahigh pressure chamber filled with pressure transmitting fluid. In oneexample, the pressure transmitting fluid is water. The generatedpressure is applied to the cannabis juice purée 921. A lid 924 is usedto seal the opening 923 of the container 922. For additional informationon HPP, see: (1) U.S. Pat. No. 9,277,763, entitled “BiopreservationMethods For Beverages And Other Foods”, filed Jun. 23, 2014 by Beckmanet al.; (2) U.S. Pat. No. 7,906,160, entitled “Protein beverage andmethod of making the same”, filed Mar. 7, 2007 by Sherwood et al.; and(3) U.S. Pat. No. 5,232,726, entitled “Ultra-high pressurehomogenization of unpasteurized juice”, filed Oct. 8, 1992 by Clark etal. (the subject matter of these patent documents is incorporated hereinin its entirety).

FIG. 58A is a perspective diagram of the packaged cannabis juice puréewith only non-decarboxylated cannabinoids. The packaged cannabis juicepurée has 120 mg of THCa and 180 mg of CBDa. The packaged cannabis juicepurée is formed by carrying out the steps set forth in method 900 suchthat the cannabis juice purée in the first step (step 910) has only raw,blended cannabis material. None of the collected cannabis material isheated. The packaged cannabis juice purée does not include anydecarboxylated cannabinoids and the packaged cannabis juice purée is notpsychoactive. In this example, the ratio of CBDa to THCa is 3:2. Theamount of CBDa in each packaged cannabis juice purée is greater than theamount of THCa, and the amount of CBD in each packaged cannabis juicepurée is greater than the amount of THC. In other embodiments, eachpackaged cannabis juice purée has ratio of CBDa to THCa taken from thegroup consisting of: 2 CBDa to 1 THCa, 1 CBDa to 1 THCa, 1 CBDa to 2THCa, 1 CBDa to 3 THCa, 3 CBDa to 1 THCa, 0 CBDa to 1 THCa (no CBDa,only THCa), and 1 CBDa to 0 THCa (no THCa, only CBDa). The packagedcannabis juice purée may be made to include or exclude non-cannabinoidcomponents of the cannabis plant that include terpenes, fatty acids,aminoacids, enzymes, vitamins, minerals, carotenoids, chlorophyll,flavonoids, and dietary fibers. Non-decarboxylated high concentratecannabis extract may also be added to the packaged cannabis juice puréeto achieve high concentrations of non-decarboxylated cannabinoids.

FIG. 58B is a perspective diagram of another embodiment of a packagedcannabis juice purée with added non-decarboxylated high concentratecannabis extract. In the example of FIG. 58B, the packaged cannabisjuice purée has 300 mg of non-decarboxylated cannabinoids from rawcannabis plant and 6,000 mg of non-decarboxylated cannabinoids fromnon-decarboxylated high concentrate cannabis extract.

FIG. 59A is a perspective diagram of a packaged cannabis juice puréewith added decarboxylated cannabinoids. The packaged frozen ice pop ofcannabis juice purée 634 is formed by carrying out the steps set forthin method 900 such that the cannabis juice purée in the first step (step910) has raw, blended cannabis material in addition to decarboxylatedcannabis infusion. The packaged cannabis juice purée includesnon-decarboxylated cannabinoids and decarboxylated cannabinoids. In thisexample, packaged cannabis juice purée has 300 mg of non-decarboxylatedcannabinoids from raw cannabis plant and 280 mg of decarboxylatedcannabinoids from decarboxylated cannabis infusion.

FIG. 59B is a perspective diagram of another embodiment of a packagedcannabis juice purée with added decarboxylated cannabis infusion andnon-decarboxylated high concentrate cannabis extract. In the example ofFIG. 59B, the packaged cannabis juice purée has 300 mg ofnon-decarboxylated cannabinoids from raw cannabis plant, 280 mg ofdecarboxylated cannabinoids from decarboxylated cannabis infusion, and6,000 mg of non-decarboxylated cannabinoids from non-decarboxylated highconcentrate cannabis extract.

FIG. 59C is a perspective diagram of another embodiment of a packagedcannabis juice purée with added decarboxylated high concentrate cannabisextract. In the example of FIG. 59C, the packaged cannabis juice puréehas 300 mg of non-decarboxylated cannabinoids from raw cannabis plantand 310 mg of decarboxylated cannabinoids from decarboxylated highconcentrate cannabis extract.

FIG. 59D is a perspective diagram of another embodiment of a packagedcannabis juice purée with added decarboxylated high concentrate cannabisextract and non-decarboxylated high concentrate cannabis extract. In theexample of FIG. 59D, the packaged cannabis juice purée has 300 mg ofnon-decarboxylated cannabinoids from raw cannabis plant, 310 mg ofdecarboxylated cannabinoids from decarboxylated high concentratecannabis extract, and 6,000 mg of non-decarboxylated cannabinoids fromnon-decarboxylated high concentrate cannabis extract.

FIG. 60 is a flowchart of a method 1000 to store packaged containershaving a cannabis juice purée. In a first step (step 1010), packagedcontainers having a cannabis juice purée are stored. For example, inFIG. 61, containers 1011 each having a cannabis juice purée are storedon a shelf 1012. The shelf 1012 may be part of a retail-store, adispensary, a storage facility, or a transport vehicle.

FIG. 62 is a table 1100 that shows the therapeutic benefits of varioustypes of cannabinoids. The amount and type of cannabinoid present ineach of the embodiments can vary depending on the specific therapeuticbenefits being targeted. The cannabis juice purée used in the variousembodiments has at least one type of cannabinoid listed in table 1100.

Although certain specific embodiments are described above forinstructional purposes, the teachings of this patent document havegeneral applicability and are not limited to the specific embodimentsdescribed above. For example, in addition to THC and CBD, othercombinations of cannabinoids can be employed. For example, CBG isanother cannabinoid that can be present in certain strains of cannabis.Non-decarboxylated CBG (CBGa) and decarboxylated CBG (CBG) can be usedin forming the cannabis juice purée. In addition, CBN is anothercannabinoid that can be present in certain strains of cannabis.Non-decarboxylated CBN (CBNa) and decarboxylated CBN (CBN) can be usedin forming the cannabis juice purée. In addition, other cannabis strainswith various terpene profiles can be added to the cannabis juice puréein the various embodiments. Accordingly, various modifications,adaptations, and combinations of various features of the describedembodiments can be practiced without departing from the scope of theinvention as set forth in the claims.

What is claimed is:
 1. A container comprising: a frozen structure of cannabis juice purée, wherein the cannabis juice purée is formed by blending cannabis plant material of a cannabis plant, wherein all of the cannabis plant material is converted into the cannabis juice purée, wherein each frozen structure of cannabis juice purée has cannabinoids that include at least one of decarboxylated cannabinoids or non-decarboxylated cannabinoids, wherein the frozen structure is disposed within an inner portion of the container, wherein the container has an upper extent, a bottom extent, a first side extent, and a second side extent, wherein the first side extent extends along a first side of the container from the upper extent to the bottom extent, wherein the second side extent extends along a second side of the container from the upper extent to the bottom extent, and wherein the first side is opposite the second side.
 2. The container of claim 1, wherein the frozen structure of cannabis juice purée is an ice pop of cannabis juice purée, and wherein the ice pop includes at least one of decarboxylated high concentrate cannabis extract, non-decarboxylated high concentrate cannabis extract, decarboxylated cannabis infusion, or heated cannabis material.
 3. The container of claim 1, wherein the container is formed from a flexible material, wherein the upper extent is adapted to form an opening such that an inner portion of the container is exposed, and wherein the first side extent is at least three times a length of the upper extent.
 4. The container of claim 1, wherein the frozen structure directly contacts the inner portion, and wherein no packaging material is disposed between the frozen structure and the inner portion of the container.
 5. The container of claim 1, wherein the first side extent is parallel to the second side extent, and wherein the upper extent is parallel to the bottom extent.
 6. The container of claim 1, wherein an edge portion of the container has a first thickness, wherein a center portion of the container has a second thickness, and wherein the second thickness is more than ten times the first thickness.
 7. The container of claim 1, wherein cannabinoids include only non-decarboxylated cannabinoids, and wherein the cannabinoids does not include any decarboxylated cannabinoids.
 8. The container of claim 1, wherein the cannabinoids include at least one cannabinoid taken from the group consisting of: cannabigerolic acid (CBGa), cannabigerovarin acid (CBGVA), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin carboxylic acid (THCVA), cannabidiolic acid (CBDA), cannabidivarin acid (CBDVA), cannabichrome carboxylic acid (CBCA), cannabichrome varinic acid (CBCVA), tetrahydrocannabinol (THC), tetrahydrocannabivarin (THCV), tetrahydrocannabivarin acid (THVA), cannabidiol (CBD), cannabidivarin (CBDV), cannabichromene (CBC), cannabichromevarin (CBCV), cannabigerol (CBG), cannabigerovarin (CBGV), cannabinerolic acid (CBNA), cannabigerovarinic acid (CBNVA), cannabinol (CBN), cannabicyclol (CBL), and cannabicyclol acid (CBLA).
 9. A method comprising: (a) forming a cannabis juice purée, wherein the cannabis juice purée is formed by blending raw cannabis material, wherein all of the raw cannabis material is converted into the cannabis juice purée, and wherein the cannabis juice purée has cannabinoids; (b) depositing the cannabis juice purée into a container without separating the blended raw cannabis material from juice of the cannabis plant; and (c) freezing the container with the cannabis juice purée to form a packaged ice pop of cannabis juice purée.
 10. The method of claim 9, wherein the forming of (a) involves blending the raw cannabis material with a thickening agent.
 11. The method of claim 10, wherein the thickening agent is taken from the group consisting of: banana, avocado, psyllium husk, tapioca, and a food-grade thickening agent, wherein the forming of (a) further involves adding a sweetening agent, a flavoring agent, fruits, or vegetables to the cannabis juice purée, wherein the sweetening agent is taken from the group consisting of: honey, stevia, fruit juice, sugar, corn syrup, and a food grade sweetener, and wherein the flavoring agent is taken from the group consisting of: fruit flavoring and a spice.
 12. The method of claim 9, further comprising: (d) placing the packaged ice pop of cannabis juice purée into a package along with other packaged ice pops of cannabis juice purée, wherein the package includes a label that provides cannabinoid profile information of the ice pops of cannabis juice purée; and (e) storing the package of packaged ice pops in a freezing temperature environment thereby maintaining the ice pops in a solid state.
 13. The method of claim 9, wherein prior to the freezing of (c) at least one of decarboxylated high concentrate cannabis extract, non-decarboxylated high concentrate cannabis extract, decarboxylated cannabis infusion, or heated cannabis material is combined with the cannabis juice purée.
 14. The method of claim 9, wherein the container is a plastic tube, wherein an end of the plastic tube has an opening, wherein the cannabis juice purée deposited in (b) passes through the opening into the inside of the container, and wherein the opening is selected from the group consisting of: a resealable opening, and a non-resealable opening.
 15. The method of claim 9, wherein the cannabinoids include at least one of decarboxylated cannabinoids or non-decarboxylated cannabinoids.
 16. The method of claim 9, wherein the packaged ice pop of cannabis juice purée has an upper extent, a lower extent, a first side extent, and a second side extent, wherein an end of the packaged ice pop of cannabis juice purée is adapted to form an opening such that the ice pop passes through the opening to be consumed, and wherein a length of the first side extent is more than three times a length of the upper extent. 